| L |
| La Marca S |
- |
TAFI 325/Ile Genotype in Old Population of Northern Italy |
| La Roche Y |
- |
Cloning Strategy and Humanization of the Potent Antithrombotic Agent 6B4, an Anti-Glycoprotein Ib Monoclonal Antibody |
| Labarque V |
- |
Impaired Platelet Adhesion on Collagen Surfaces and Secretion Defect in Duchenne Muscular Dystrophy Patients |
| L'Abbé D |
- |
Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm |
| Labelle A |
- |
Anti-FVIII Inhibitor Development in Hemophilic Mice is Dependent Upon Genetic Background, Adjuvant Type, Injection Site, and Frequency of Antigen Exposure |
| Labelle A |
- |
Characterization of Recombinant Canine Factor VIII and Quantitative Determination of Factor VIII in Canine Plasma |
| |
- |
Disruption of an Immunogenic Epitope in the FVIII C2 Domain Results in the Prevention of Anti-FVIII-C2 Inhibitor Formation in BALB/c-FVIIIKO Hemophilic Mice |
| |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| |
- |
Prevention of Anti-FVIII-C2 inhibitor formation Post Protein infusion in Hemophilic Mice By Prior Oral and/or Nasal Exposure of the FVIII-C2 Domain |
| Lablanche JM |
- |
Plasma Levels of Tissue Factor and von Willebrand Factor Predict Long Term Clinical Outcome after Percutaneous Coronary Revascularization |
| Lacapère JJ |
- |
Glycoprotein VI Structure-Function Relationship: Identification of Collagen Binding Domains Using GPVI/FcaR Chimera |
| Lacerda MVG |
- |
Hemostatic Changes in Patients with Malaria |
| Lachance P-A |
- |
Prospective Sensitivity Comparison of Three Different D-Dimer Assays for Venous Thromboembolic Disease Exclusion Using a Standardized Diagnostic Algorithm |
| Lachassinne E |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| |
- |
Perinatal or Fetal Thrombosis in Babies Allowing Detection of the Anti-phospholipid Syndrome in Mothers |
| Lackner KJ |
- |
Multicenter Evaluation of BCS® XP A Further Development of the Widespread BCS® Coagulation Analyzer |
| |
- |
Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study |
| Lacroix S |
- |
Clinical and Laboratory Response to rFVIIa and APCC in a Rare Case of Severe Congenital Factor VII Deficiency with an Inhibitor |
| |
- |
Spurious Decrease of Inhibitor Levels in Plasma Containing rFVIIa |
| Lacroix-Desmazes S |
- |
Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII |
| Lacut K |
- |
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based CaseControl Study |
| Lacut K |
- |
Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study |
| |
- |
Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| Lacut K |
- |
Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial |
| Lacut K |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study |
| |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| Ladenvall C |
- |
C-reactive Protein Polymorphisms and Ischemic Stroke |
| Ladenvall P |
- |
C-reactive Protein Polymorphisms and Ischemic Stroke |
| |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Ladenvall C |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Ladouzi A |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| LaDuca FM |
- |
Effective Anticoagulation Self-Management in a Diverse Population of Oral Anticoagulation Patients Using the Protime System |
| LaDuca F |
- |
Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI) |
| |
- |
Evaluation of the Anticoagulant Effect of Enoxaparin by Using Clot Based Point of Care Tests |
| LaDuca FM |
- |
A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System |
| Laffan M |
- |
Recombinant VIIa in Uncontrolled Haemorrhage |
| Laffan MA |
- |
Loss of Terminal Fucose Expression in Bombay Phenotype Produces Reduced Plasma VWF Level Through a Conformation-Related Increased Susceptibility to ADAMTS-13 |
| Lafon I |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| Lafont A |
- |
Low Molecular Weight Fucoidan Is More Effective Than Low Molecular Weight Heparin in Preventing Arterial Thrombosis in a Rabbit Model |
| Lagerqvist B |
- |
The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome |
| |
- |
Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome |
| Lages GFG |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| Lages P |
- |
Successful Inhibitor-Elimination with Rituximab in Acquired Hemophilia A and a Patient with a Carrier Status for Hemophilia A Two Case Reports |
| Lages GFG |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| Lages P |
- |
A Novel Mutation (Asp36Tyr) in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Causes Moderately Increased Coumarin Doses |
| Laggner AN |
- |
Platelet Hyperfunction and Low Response to Aspirin Predict Re-events in Patients With Acute Coronary Syndromes During Long Term Follow Up |
| Laguna P |
- |
Thrombosis Comlications in Children with Hemophilia after Insertion of Cental Venous Carheters |
| |
- |
The Use of Factor VII(rFVIIa) in Surgical Correction of Hypospadiasis in a Child with Haemophilia A Complicated by Presence of Factor VIII Inhibitor |
| Laguna P |
- |
Surgery in Children with Haemophilia complicated by Inhibitors |
| Lahav J |
- |
Substitutions of Cysteine Residues in b3 Affect aIIbb3 Integrin Processing and Activation |
| Lahav J |
- |
Redox-Regulated Coupling of ADP Receptor Signaling and Integrin Function in Platelets |
| Lahtinen M |
- |
Nitric Oxide Enhances Eosinophil and Basophil Degranulation without Affecting Contact and Complement Activation |
| Laidlaw S |
- |
Clinical Use of Protamine for the Emergency Reversal of Anticoagulation with Low Molecular Weight Heparin (LMWH) |
| Lak M |
- |
Carrier Testing of Hemophilia B by SSCP and Sequencing in One Iranian Family |
| Lake JD |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| Lakhani P |
- |
P2Y12 Receptor Mediated Thromboxane A2 Generation in Human Platelets Occurs in A GIRK Dependent Manner |
| Lalezari S |
- |
A Novel Mutation In Platelet Glycoprotein Iba Causing BernardSoulier Syndrome In A Bucharian Jewish Family |
| |
- |
Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone |
| Lally C |
- |
Sickle-cell Trait and the Risk of Venous Thromboembolism |
| |
- |
The Relationship of the GAS6 Gene to Myocardial Infarction in African-Americans and Caucasians |
| |
- |
The Relationship Between Genetic Variants in the Endothelial Protein C Receptor and Venous Thromboembolism |
| Lally H |
- |
The Association Between Diabetes and Venous Thromboembolism in African Americans and Caucasians and the Relationship with Peroxisome Proliferator-Activated Receptor Polymophisms |
| Lally C |
- |
Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with Race, Age, ABO Blood Group and Co-Morbid Conditions |
| Lalonde L |
- |
Optimizing Thromboembolic and Stroke Prevention: Interim Analysis of a Randomized Controlled Trial of Pharmacist-Managed Oral Anticoagulotherapy (PHARMA Trial) |
| Lam JK |
- |
Roles of Arg257 and Arg1176 of ADAMTS13 in Its Proteolysis and Its Activity against VWF |
| Lam CCK |
- |
Platelet Function Monitoring by the PFA-100® in Patients Taking Non-Aspirin NSAIDs |
| Lam P |
- |
Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis |
| Lam M |
- |
Validation of Overt Disseminated Intravascular Coagulation (DIC) Scoring Algorithm Use in Critically Ill Patients: Correlation with Inflammatory Markers and APACHE and SOFA Scores |
| Lamb CB |
- |
Sustained Platelet Adhesion and VWF String Formation in Stimulated Venules Of Adamts13-/- Mice |
| Lambert J-F |
- |
Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells |
| Lambertenghi D |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Lambertenghi Deliliers G |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Lambie J |
- |
Ambulatory Therapy of Patients with Free-Floating Proximal Deep Vein Thrombosis Is Safe |
| |
- |
Prospective Study of the Diagnosis of Pulmonary Embolism (PE) Using Pretest Probability (PTP), D-Dimer (DD) and Appropriate Imaging |
| Lammer J |
- |
Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model |
| Lämmle B |
- |
A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings |
| |
- |
A Baltic Origin of the Common ADAMTS13 Mutation 4143insA |
| |
- |
ADAMTS13 Is Present in Human Platelets and Strongly Expressed on COAT-Platelets |
| Lamonica R |
- |
Are Discard Tubes Needed for PT and APTT Assays? |
| Lamping DL |
- |
The VEINES-QOL/Sym Questionnaire Is a Valid and Reliable Measure of Quality of Life in Patients with Deep Venous Thrombosis |
| Lamprecht S |
- |
A Model of Femoral Arterial Stenosis to Evaluate Anti-platelet Drugs in Baboons |
| Landau M |
- |
Further Characterization of the Mutation in Blade 2 of the aIIb b-Propeller That Causes Glanzmann Thrombasthenia in Palestinian Arabs |
| |
- |
A Novel Mutation In Platelet Glycoprotein Iba Causing BernardSoulier Syndrome In A Bucharian Jewish Family |
| |
- |
Identification and Characterization of 10 Novel Mutations Causing Factor XI Deficiency |
| Landgraf H |
- |
Prophylaxis of Thromboembolic Complications in Acute Ischemic Stroke with the Low Molecular Weight Heparin Certoparin (PROTECT) |
| Landmann T |
- |
Gene Polymorphisms of Hemostasis And Lipid Metabolism in Apparently Healthy Individuals from Southwest Germany |
| Landolfi R |
- |
Platelets Morphological and Functional Characterisation in a Novel Case of Grey Platelet Syndrome: Defective Response to Thrombin, PAR1-AP And PAR4-AP and Correlation with Alpha-Granules Content in the Patient and Four Relatives |
| Landoni VI |
- |
Regulation of Megakaryocyte Generation by Monocytes/Macrophages |
| Landoni V |
- |
Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents |
| Landskroner K |
- |
Increased Sensitivity for Measurement of Factor VIII Using ROTEG and FVIII-/- Mouse Blood Supplemented with rFVIII |
| |
- |
Cross-Species Pharmacologic Evaluation of Plasmin as a Direct-Acting Thrombolytic Agent: ex vivo Evaluation for Large Animal Model Development |
| Lane DA |
- |
Roles of Arg257 and Arg1176 of ADAMTS13 in Its Proteolysis and Its Activity against VWF |
| Lane DA |
- |
Directing Thrombin |
| Lane DA |
- |
Characterisation of Anti-ADAMTS13 Autoantibodies from a Patient with Thrombotic Thrombocytopenic Purpura (TTP) |
| |
- |
Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression |
| |
- |
ADAMTS13 Substrate Recognition of the Von Willebrand Factor A2 Domain |
| Lane D |
- |
Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men |
| Lane1 DA |
- |
EPCR Cleavage and inactivation by Neutrophil Proteinase 3 |
| Lang S |
- |
Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo |
| Lange T |
- |
Influence of Platelet Transfusion on Thrombin Generation in Patients with Bone Marrow Transplantation |
| Langer F |
- |
CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation |
| |
- |
Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy |
| Langer F |
- |
Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia |
| Langer C |
- |
Elevated Alpha 1-Antitrypsin Is a Risk Factor for Arterial Ischemic Stroke in Childhood |
| |
- |
Pregnancy of a Libanese Woman with Homozygous Protein C deficiency |
| Langer F |
- |
Cellular Effects of Heparin-PF4 Antibodies and Its Relevance to the Pathogenesis of Heparin-Induced Thrombocytopenia |
| Langer F |
- |
Platelet Microparticles (PMP) Are Increased in Patients with Localized Prostate Cancer and Correlate with Plasma Tissue Factor (TF) Antigen Levels |
| Langer F |
- |
Importance of Pre-Analytical Variables in the Measurement of Platelet-Derived Microparticles |
| Langford CF |
- |
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles |
| Langhorne P |
- |
Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis |
| Lanir N |
- |
Tissue Factor Is Expressed and Active on Cultured Human Trophoblast Cell Surface; Possible Regulation by Angiogenic Stimuli |
| Lanke E |
- |
Cys570Ser Mutation in the von Willebrand Factor Propeptide in Recessive von Willebrand Disease |
| |
- |
Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1 |
| Lanza F |
- |
Platelet Activation Through the GPIb-V-IX Complex: Role of Individual Subunits and the Intracellular Face |
| Lanza F |
- |
Diverging Signaling Events Control the Pathway of GPVI Down-Regulation in vivo |
| |
- |
Specific Role of the GPVI/FcRg Complex in Promoting Thrombus Formation Following Superficial But Not Deep Arterial Injury |
| |
- |
Mice Lacking the Platelet Glycoprotein Ib Beta Intracellular Domain Display Resistance to Thrombosis But Normal Bleeding Times |
| Lap PAJ |
- |
Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients |
| |
- |
Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII |
| Lap P |
- |
The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis |
| |
- |
The Effect of Statin Therapy on Coagulation and Fibrinolysis in Patients with Heterozygous Familial Hypercholesterolemia |
| |
- |
The Nijmegen Hemostasis Assay Is a Useful Tool to Screen Thrombophilia |
| |
- |
Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay |
| Lapini I |
- |
Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk |
| |
- |
Homocysteine, Vitamins and C-reactive Protein in the InCHIANTI Study |
| |
- |
The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective CaseControl Study |
| |
- |
eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms |
| |
- |
Vitamin B6 Serum Level and Inflammation and in the InChianti Study |
| Lapinski M |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| Laplace M-C |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Laporte S |
- |
Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry |
| Laporte S |
- |
Fatal Vascular Outcomes Following Major Orthopedic Surgery |
| |
- |
Anti-fibrinolytic Use in Major Orthopaedic Surgery Reduces Allogeneic Blood Transfusion. A Meta-analysis of Randomised Trials |
| |
- |
Clinical Experience with Retrievable ALN Vena Cava Filters |
| Laposata M |
- |
Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR |
| Lärfars G |
- |
A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information |
| Lari B |
- |
ACE DD Genotype: A Predisposing Factor to Abdominal Aortic Aneurysm |
| |
- |
Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study |
| Larina LE |
- |
The Long-term Future of Patients Had Had Henoch-Schonlein Purpura in Childhood |
| |
- |
Ulcerous Colitis in Children with Hemophilia A |
| Larina LE |
- |
Family with Inherited f.X Deficiency. Case Report |
| Larisa C |
- |
Inhibition of Catalytic Activity of Plasmin by Recombinant Human Prion Protein |
| Larkin E |
- |
Absolute CD62 Expression and PAC-1 Binding Correlate with Decreased PFA-100 Closure Times Seen in Severely Injured Patients |
| Larkin EC |
- |
Prevalence and Clinical Utility of IgA Isotype Antiphospholipid Antibodies |
| Larkin D |
- |
Occupancy-Dependent Interaction Between Platelet Integrin aIIbb3 and ICln |
| |
- |
Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes |
| Larouche V |
- |
Spurious Decrease of Inhibitor Levels in Plasma Containing rFVIIa |
| Larsen LH |
- |
Visualization of the Continuous APTT Coagulation Signature Methods and Correlations to Continuous Thrombin Generation |
| Larsen B |
- |
Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism |
| Larsen LH |
- |
Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values |
| Larson MK |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| |
- |
Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow |
| Larsson R |
- |
Heparinization of the Pancreatic Islet Surface as a Mean to Reduce Harmful Blood Clotting after Intraportal Islet Transplantation |
| Lasmar MC |
- |
Natural Anticoagulation Evaluation in Type 2 Diabetes |
| |
- |
Type 2 Diabetes: Endothelium Lesion and Fibrinolytic System Markers Assessment |
| |
- |
Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Plasma Levels of Homocysteine in Patients with Type 2 Diabetes |
| Lassen MR |
- |
The Benefit-to-Risk Ratio of Fondaparinux Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery Is Independent of Age |
| |
- |
Measuring Fragment 1 + 2 in Spot Urine to Determine the Thrombotic Potential after Hip Arthroplasty |
| |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Lassila R |
- |
Limited Antiplatelet Effect of Clopidogrel In Aspirin-treated Patients with Coronary Artery Disease Associates with Cardiac Endpoints |
| |
- |
Platelet Function Analyzer (PFA-100R) Detects Intranasal Desmopressin Responses in Patients with Hemophilia A and von Willebrand Disease |
| |
- |
Different Monitoring Methods for in Vitro and in Vivo Lepirudin, a Direct Thrombin Inhibitor: Diluted Thrombin Time (dTT), Activated Partial Thromboplastin Time (aPTT) and Ecarin Clotting Time (ECT) |
| Lastella P |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Latger-Cannard V |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Lathrop M |
- |
A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels |
| Latimer M |
- |
Successful Immune Tolerisation in an Adolescent Severe Haemophilia a Patient with an Inhibitor: A Case Report |
| |
- |
Extensive Jugular and Subclavian Vein Thrombosis after Ovarian Hyperstimulation Syndrome as a Complication of In Vitro Fertilization: A Case Report |
| Lattuada A |
- |
A New Automatic Method to Measure Adamts 13 |
| |
- |
An Innovative Method to Measure von Willebrand Factor Activity and Adamts13 |
| Lau A |
- |
Effect of Mechanical Ventilation on the Hemostatic State of the Newborn |
| Lau P |
- |
Recombinant Activated Factor VII (rFVIIa, Novoseven®) in Coagulopathic Trauma Patients Significantly Reduces Blood Product Usage: Post-Hoc Subgroup Results from an International, Multi-Centre, Randomised, Placebo-Controlled, Double-Blind, Prospective Clinical Trial |
| Lau LM |
- |
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function |
| Lau H |
- |
The Generation of Thrombin by High Dose Recombinant Factor VIIa Can Be Mimicked by Lower Factor VIIa Concentrations Combined with Tissue Factor |
| Lau WC |
- |
Pre-Existent Variability in Platelet Response to ADP Accounts FOR Clopidogrel Resistance |
| Lau W |
- |
Cyclosporine Reduces the Platelet Inhibitory Effect of Clopidogrel in Cardiac Transplant Patients |
| Lau A |
- |
Comparison of the Anticoagulant Effects of Melagatran and LMWH in an Acquired Antithrombin Deficiency in Children with ALL Treated with L-Asparaginase: An Ex Vivo Study |
| Lau LM |
- |
Disruption of the Mouse Tetraspanin Superfamily Member, TSSC6 Gene Reveals an Essential Role in Platelet Function |
| Lau A |
- |
Comparison of Continuous and Subsampling Determination of Thrombin Generation in the Presence of Anticoagulants |
| Lau W |
- |
Dose-Dependent Clopidogrel-Atorvastatin DrugDrug Interaction Determined by Light Transmission Aggregometry |
| Lau A |
- |
Comparison of Continuous and Subsampling Methods for Analysis of Thrombin Generation |
| Laudati G |
- |
Semi-Synthetic Sulfaminoheparosans Induce Tissue Factor Pathway Inhibitor Release by Human Umbelical Vein Endothelial Cells (HUVEC) |
| Laudenbach L |
- |
Immune Tolerance to Factor IX inhibitor |
| Lauer P |
- |
Thromboelastogram Assays To Detect Hemostatic Abnormalities In Factor XIIIA Deficient Transgenic Mice: Substitution With Human Plasma Factor XIII |
| Laumonnier Y |
- |
The Annexin II Heterotetramer is a Receptor for the Plasmin-Induced Signaling in Human Peripheral Monocytes |
| Laurens N |
- |
Effect of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) and Pancreatic Carboxypeptidase B (CPB) on the Capillary Tube Formation in an in vitro Angiogenesis System |
| Lauretani F |
- |
Vitamin B6 Serum Level and Inflammation and in the InChianti Study |
| Laurian Y |
- |
Treatment of Glanzmann's Thrombasthenia (GT): A Prospective Observational Registry on the Use of Recombinant Human Activated Factor VII (rFVIIa) and Other Hemostatic Agents |
| Lauritzen B |
- |
Effect of rFVIIa Following Experimental Hemodilution with Two Different Colloids in a Rabbit Cuticle Bleeding Model |
| Laux V |
- |
Inhibition of thrombin generation by Otamixaban (XRP0673), a direct and selective factor Xa inhibitor |
| |
- |
Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor |
| Laux V |
- |
The New Anticoagulant Octaparin Displays High Antithrombotic Action in Venous Thrombosis in Rabbits and Rats without Impairment of Hemostasis |
| Lauzon M |
- |
Calculation of the Direct INR Calibration Line Using Linear and Orthogonal Regression |
| |
- |
Long Term Storage and Stability of Urinary 11-Dehydro Thromboxane B2 |
| Lauzon M |
- |
Effect of Sample Collection Conditions on Interleukin-18, Serum Amyloid A and Monocyte Chemo-Attractant Protein-1 ELISA Measurement in Human Serum |
| Lavador M |
- |
Correlation Between Thromboelastographic and Whole Blood Aggregometrical Aspirin-Resistance Values and Neurological Events in Ventricular-Assist Device (VAD) Patients |
| |
- |
Neurologic Injury during Ventricular Assist Device (VAD) Support: Association with Rebound Hypercoagulability after Heparin Withdrawal |
| Lavender P |
- |
Isolation of Megakaryocytic Cells over-Expressing TRPC Channels |
| Lavender FL |
- |
Identification of the Presence of Polymorphic Sites within Exon 28 of the von Willebrand Factor Gene Using Fluorescent SSCP |
| Lavend'homme R |
- |
Antigen Binding Site Glycosylation Determines the Anticoagulant Activity of a Type II Factor VIII Antibody without Modifying Affinity or Epitope Specificity |
| Laverda AM |
- |
Cerebral Sinovenous Thrombosis in Children |
| Lavergne JM |
- |
13 Novel Mutations in the Factor VIII Gene in the Nijmegen Hemophilia A Patient Population |
| Lavergne LM |
- |
DDAVP Treatment Is Not Recommended in Patients with von Willebrand Disease Type 2N |
| Lavergne JM |
- |
Mutation Analysis of the Factor VIII Gene in 224 Iranian Families with Haemophilia A |
| Lavigne-Lissalde G |
- |
Fine Epitope Mapping of Human Monoclonal Antibodies Directed Against the B Domain of Factor VIII |
| Lavigne-Lissalde G |
- |
Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C |
| Lavin MF |
- |
Slow Lysis of Porcine Blood Clots Is Caused by Resistance of Plasminogen to Activation |
| Lavin M |
- |
Characterisation of the Anticoagulant Properties of a Phospholipase A2 from the Venom of the Australian King Brown Snake (Pseudechis australis) |
| Lavinha J |
- |
The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients |
| Lavoretano S |
- |
Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13 |
| |
- |
Prospective Study on Acute Thrombotic Microangiopathy (TMA) after Bone Marrow Transplantation (BMT): Role of ADAMTS13, VWF:Ag and High Molecular Weight von Willebrand Factor (HMW : VWF) |
| Lavrentieva NN |
- |
Ulcerous Colitis in Children with Hemophilia A |
| Lavrentyeva I |
- |
The Occasions of Factor XII Deficiency in Children |
| Lavrova E |
- |
Relationship Between Circulating Thrombomodulin Levels and Latent: Progression of Atherosclerosis in Type 2 Diabetic Patients |
| |
- |
Relationship between Endothelial Haemostatic Markers in Type 2 Diabetic Patients |
| Law PB |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Lawler J |
- |
Thrombospondin-1 Secures Thrombus Adherence in vivo by Protecting (Sub)Endothelial VWF from Leavage by ADAMTS13 |
| |
- |
Thrombospondin as a Regulator of von Willebrand Factor Multimer Size |
| Lawler P |
- |
Case Report of Patient with Homozygous FXII deficiency, Heterozygous FXI deficiency and Antiphospholipid Antibodies |
| Lawmin JC |
- |
Platelet Function Monitoring by the PFA-100® in Patients Taking Non-Aspirin NSAIDs |
| Lawnicka H |
- |
Thalidomide Affects Early Phases of VEGF Stimulated Angiogenesis in Human Endothelial Cells |
| Lawrie AS |
- |
Lupus Anticoagulant Testing Using a Dilute Prothrombin Time with Confirm Procedure |
| Lawson HL |
- |
Isolated Alpha-2 Antiplasmin Deficiency Presenting in a 63 year Old Man |
| |
- |
Sporadic Occurrence of Warfarin Resistance Secondary to a Val29Leu Mutation In The VKORC1 Protein |
| Lawson J |
- |
Safety, Immunogenicity, and Efficacy of Recombinant Human Thrombin as a Topical Surgical Hemostat: Integrated Results for a Multi-Surgery Phase 2 Program |
| Lawson HL |
- |
Production of a Recombinant Peptide Substrate for the Fluorescence Based Assay of ADAMTS13 |
| Lay AJ |
- |
A Novel Role for Maternal Protein C in Embryonic Development |
| Lazarchick J |
- |
Anti-phospholipid Antibody Syndrome in the Neonatal Period: Report of a Rare Case |
| Lazarev AP |
- |
Enhancement of Catalytic Activities of Thrombin and Trypsin By Human Insulin |
| Lazur J |
- |
Genetic and Phenotypic Analysis of Families with Inherited Hypo- and Dys-fibrinogenemia |
| Lazzari M |
- |
Partial Purification of ADAMTS-13 |
| Lazzari MA |
- |
Genetic Study of von Willebrand Factor in Twenty-two Members of an Argentinian Family |
| |
- |
Cyclic AMP Protects Stem Cell (CD34+) Apoptosis |
| Lazzari M |
- |
Von Willebrand Factor and ADAMTS-13 in 23 Doberman Pinschers Dogs |
| Lazzari MA |
- |
Ultralarge Multimers of Von Willebrand Factor (VWF) And ADAMTS13 Activity In Plasma From BALB/C And C57Bl/6J Mice At Physiological Conditions |
| |
- |
Evaluation of Fibrinolytic Activity and Major Hemorrhages in Probable Type 1 Von Willebrand Disease |
| |
- |
Oral Anticoagulation in Patients over 80 Years with Atrial Fibrillation |
| Lazzari M |
- |
Determination of ADAMTS-13 Activity in 13 Patients with Ischemic Stroke |
| Lazzari MA |
- |
Retinal Vein Occlusion and Anticoagulation: Does It Offer Any Benefit? Report of Two Cases |
| |
- |
Comparative Effects of Nitroxil (HNO) and NO on Platelet Function and Tyrosine Phosphorilation Pattern of Activated Human Platelets |
| |
- |
Hyperhomocysteinemia, Anticardiolipin Antibodies, and Risk for Vascular Access Thrombosis in Hemodialysis Patients |
| |
- |
Behaviour of the Two-Step Coagulation Assay to Identify Antib2-glycoprotein I (ab2GPI)-Lupus Anticoagulant (LA) in Patients with Antiphospholipid Antibodies |
| |
- |
Regulation of Megakaryocyte Generation by Monocytes/Macrophages |
| Lazzari M |
- |
Anti Factor VIII Inhibitor: A Single Institution Experience |
| Lazzeri C |
- |
High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study |
| Lazzerini G |
- |
Aspirin-Clopidogrel Combination and Trans-Esophageal Echo Parameters Predictive of Thromboembolism in Atrial Fibrillation: The CLAAF-Pilot Study |
| |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| Le S |
- |
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization |
| |
- |
GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism |
| Le TNM |
- |
Two Parallel Prothrombin Activator Systems in Eastern Brown Snakes |
| Le Bonniec BF |
- |
Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas |
| Le Cam-Duchez V |
- |
Protein Z Polymorphisms, Protein Z Plasma Concentration and Severe Pre Eclampsia |
| Le Cam-Duchez V |
- |
Heparin-PF4 Elisa Antibodies Detection Is Not Relevant to Diagnose HIT During Sepsis |
| Le Cam-Duchez V |
- |
Protein Z Polymorphisms and Cerebral Venous Thrombosis |
| Le Cam-Duchez V |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| Le Cam-Duchez V |
- |
Activated Protein C Resistance and Factor V Arg306Thr Mutation: A Case Report |
| Le Flem L |
- |
Effect Of BAY 59-7939 A Novel, Oral, Direct Factor Xa Inhibitor on Clot-Bound Factor Xa Activity in vitro |
| |
- |
Atypical Mutations of the Prothrombin Gene Located at 20209, 20218 and 20219 Position: A Report of 10 Patients with Venous Thromboembolism History |
| Le Gal G |
- |
Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study |
| Le Gal G |
- |
Fibrinogen-Aa Thr 312 Ala and Factor XIII Val 34 Leu Polymorphisms in Idiopathic Venous Thromboembolism |
| Le Gal G |
- |
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based CaseControl Study |
| Le Gal G |
- |
Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study |
| Le Gal G |
- |
Derivation and Validation of a Simple Standardized Clinical Score to Predict Pulmonary Embolism in Emergency Patients: The Revised Geneva Score |
| Le Gal G |
- |
Differential Value of Risk Factors and Clinical Signs for the Diagnosis of Pulmonary Embolism in Suspected Patients According to Age |
| Le Gal G |
- |
Supperiority of Intermittent Pneumatic Compression of the legs over Elastic Stockings to Prevent Venous Thrombosis in Patients with Acute Intra-Cerebral Hemorrhage: A Randomized Trial |
| |
- |
Multi-detector Row Computed Tomography in Outpatients with Suspected Pulmonary Embolism |
| Le Gal G |
- |
Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study |
| Le Gall G |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| Le Gall C |
- |
Inappropriateness of Diagnostic Management in Patients with Suspected Pulmonary Embolism: Frequency, Predictors and Association with Outcome |
| Le Gall G |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| Le Martelot MT |
- |
Soluble CD146 in Women with Unexplained Pregnancy Loss: A New Insight. A Paired CaseControl Study |
| Le Toumelin P |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| Le Van Kim C |
- |
Increased Adhesion of Erythrocytes from Patients with Polycythemia Vera Is Mediated by Lu/B-CAM |
| Leach JK |
- |
Reduced Bleeding Achieved through the Encapsulation of a Clot-busting Drug |
| Leadley RJ |
- |
Paradoxical Example of Warfarin Exerting Anti-Thrombotic Effect without Significantly Altering Template Bleeding Times in Rabbits |
| Leadley Jr RJ |
- |
Factor Xa-Directed Inhibition in Plasma from Patients Undergoing Coumadin Treatment: Observations Relevant to Bridging Therapy |
| |
- |
Localization of Factor Va and Factor Xa Binding to Lipid Rafts in Human Platelets |
| League S |
- |
The Relationship of the GAS6 Gene to Myocardial Infarction in African-Americans and Caucasians |
| League SC |
- |
The CXCL 16 Chemokine Is Induced by Angiotensin II in the U-937 Human Monocytic-Derived Cell Line |
| Leal SR |
- |
Current Transfusion Practices in two Autonomous Regions in Spain: Castilla La Mancha and Extremadura. Results from the Spanish Critical Care Society Hemoderivatives Working Group |
| Leamy A |
- |
Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis |
| Lear JD |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Leary J |
- |
Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium |
| Leathurby Y |
- |
A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis |
| Leblanc T |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Lebrun S |
- |
Initial Data on the Effects of Long-term Cigarette Mainstream Smoke Exposure and High Fat Diet in Apolipoprotein E-deficient Mice |
| Lecchi A |
- |
Platelet Aggregation Studies: Autologous Platelet-Poor Plasma Inhibits Platelet Aggregation When Added to Platelet-Rich Plasma to Normalize Platelet Count |
| |
- |
Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial |
| Lechler RI |
- |
Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury |
| |
- |
Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection |
| Leclair C |
- |
Marginal Effect of Interference of Simvastatin on Clopidogrel Antiplatelet Effectiveness Assessed by Measures of Platelet Activation and Aggregation |
| Lecompte T |
- |
Acquired Activated Protein C Resistance Associated with Pulmonary Arterial Hypertension Is Revealed by Calibrated Automated Thrombography |
| Lecompte T |
- |
Lupus Anticoagulants IgG with or without Anti-b2-Glycoprotein I Induced Acquired Activated Protein C Resistance Evidenced by Calibrated Automated Thrombography |
| |
- |
Insensitivity of Thrombin Potential to Activated Protein C Due to Antibody-Mediated Qualitative or Quantitative Protein S Deficiencies |
| Lecut C |
- |
Crosstalk Between Integrins a2b1 and aIIbb3 during Platelet Activation |
| Lee LH |
- |
Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study |
| Lee WC |
- |
Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study |
| Lee LH |
- |
Evaluation of the Quality of Oral Anticoagulation Management in an Anticoagulation Clinic (ACC) |
| Lee A |
- |
Evaluation of the Warkentin 4 T's Clinical Prediction Tool for Heparin-Induced Thrombocytopenia (HIT): Comparison to the Chong's HIT Classification Score |
| Lee SC |
- |
Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3 |
| Lee F |
- |
Adhesive Surface Determines Raft Composition in Platelets Adhering Under Flow |
| Lee AYY |
- |
Antithrombotic Therapy in Cancer Patients |
| Lee CA |
- |
Chromogenic and Fluorogenic Thrombin Generation Assays in Factor XI Deficiency: Correlation with Bleeding Phenotype |
| Lee KS |
- |
Antiplatelet Activity of KR-32560, a Novel Selective Sodium/hydrogen Exchanger-1 Inhibitor |
| Lee SM |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Lee YM |
- |
Inhibitory Effects of Andrographolide on LPS-Induced Tissue Factor Expression in Human Monocytic THP-1 Cells |
| Lee R |
- |
Successful Management of Pregnancy in Women with a History of Thrombotic Thrombocytopenic Purpura: A Role for ADAMTS 13 Monitoring |
| Lee CA |
- |
A Diagnostic Challenge: Occurrence of Acquired Haemophilia A in Two Patients on Warfarin Therapy |
| Lee CA |
- |
Case Report of Patient with Homozygous FXII deficiency, Heterozygous FXI deficiency and Antiphospholipid Antibodies |
| Lee K |
- |
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication |
| Lee LH |
- |
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication |
| Lee WC |
- |
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication |
| Lee CA |
- |
The Factor XI Deficiency Database: An Interactive Web Database of Mutations, Phenotypes and Structural Analysis Tools |
| Lee KW |
- |
Circulating Endothelial Cells in Acute Ischaemic Stroke |
| Lee DP |
- |
Reduction of Ex Vivo Thrombus Evolution with Anti-Platelet Therapy during Percutaneous Coronary Intervention: The REVEAL Study |
| Lee F |
- |
Lipid Rafts Facilitate the Interaction of PECAM-1 with the GPVI-FcRg Complex in Human Platelets |
| Lee KW |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| Lee CA |
- |
Obstetric Experience of Carriers of Haemophilia |
| |
- |
Could Haemostasis in Haemophilia A Be Normalised by Factor VIII (FVIII) Concentrates at Levels below 1 IU/mL? Studies with Various Methods of Thrombin Generation |
| Lee T |
- |
Effect of GpIIb-IIIa on the Point of Care Coagulation Tests in Patients Undergoing Percutaneous Coronary Intervention (PCI) |
| Lee CA |
- |
Association of Estrogen Receptor-Alpha Gene Polymorphisms with Deep Vein Thrombosis; Results of the Mega Study |
| Lee JJ |
- |
The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction |
| Lee SH |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Lee ACC members PL |
- |
Evaluation of the Quality of Oral Anticoagulation Management in an Anticoagulation Clinic (ACC) |
| Leebeek FWG |
- |
The Distribution Of Central, Segmental And Sub-Segmental Pulmonary Emboli In Multi- And Single-Row Helical CT |
| |
- |
Pathogenesis of Increased VWF Levels and the Association with the Risk of Ischemic Stroke: Proteolysis, Inflammation or Genetic Variation? |
| |
- |
C-reactive Protein in Combination with Clinical Decision Rule and D-Dimer to Safely Rule out Pulmonary Embolism |
| |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| |
- |
Genetic Variation in ADP-receptor P2Y12 is Associated with the Stability of Platelet Aggregates in Healthy Subjects |
| Lefkowitz J |
- |
Use of the D-Dimer for Exclusion of VTE: Difficulties Revealed through the Proficiency Testing Program of the College of American Pathologists (CAP) |
| Lefrant JY |
- |
Anti-factor V Auto-Antibody after the Use of Recombinant Activated Protein C |
| Legendre P |
- |
Combination of Loss of Function of Recombinant R1334A-VWF and Gain of Function of R1336A-VWF Results in a Loss of Function of RKR1334-1335-1336A-VWF |
| Legendre P |
- |
Slower Translocation of Platelets at High Shear Rate without Increased Calcium Signals on Type 2B Recombinant Von Willebrand Factor |
| Legendre P |
- |
Increased outside-in Signaling and Adhesive Functions under Shear Conditions of Cells Expressing the aIIbb3T562N Integrin |
| Leggett D |
- |
The Use of Temporary IVC Filters for the Prevention of Pulmonary Embolism in High Risk Patients |
| Leggo J |
- |
A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A |
| |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| |
- |
A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G) |
| Legnani C |
- |
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions |
| |
- |
Extremely Poor Quality of Oral Anticoagulation (OAT) Control during the First Three Months after Unprovoked Venous Thromboembolism (VTE) is a Risk Factor for Long Term Recurrence and is Associated with Higher D-Dimer Levels |
| |
- |
D-Dimer and Factor VIII Are Independent Risk Factors for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| |
- |
Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis |
| Legnani C |
- |
Shorter aPTT Values Are Associated with Increased Risk of Recurrence of Venous Thromboembolism (VTE) after Oral Anticoagulation (OA) Withdrawal |
| Legnani C |
- |
D-Dimer But Not Residual Venous Obstruction is a Risk Factor for Recurrence after Anticoagulation Withdrawal for a First Idiopathic Deep Vein Thrombosis |
| |
- |
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized Prolong Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) |
| Legnaro A |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Legrand C |
- |
Strong Antithrombotic Effect of the Type III Collagen-Related Octapeptide (KOGEOGPK) in the Mouse |
| |
- |
Shear Stress Induced Release of Von Willebrand Factor and Thrombospondin-1 in Huvec Extracellular Matrix Enhances Breast Tumour Cell Adhesion |
| Legrand E |
- |
S6-Kinase as a Possible Target for the Angiogenic Activity of Interleukin-4 |
| Legrand C |
- |
TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts) |
| Legrand E |
- |
The Stable Prostacyclin Analog Iloprost Induces The Production of the Angiogenic Factor Oncostatin M by Monocytes in a p38K-dependent Pathway |
| Lei TC |
- |
Induction of Tolerance by Gene Therapy with B-cells Expressing Ig Fusion Proteins: Pre-clinical Success in Naïve and Immune Hemophilia A Mice |
| Leichsenring I |
- |
Results of the Master Lot Calibration of a New Coagulation Monitoring System for Patient Self Testing |
| Leis LA |
- |
Platelet Shape Change Stimulated by Low Concentration TP Receptor Agonist Is Independent of p38 MAP Kinase Pathway Activation But Requires Myosin Activation |
| Leisner TM |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| Leisner R |
- |
A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia |
| Leissinger CA |
- |
Prophylaxis with Factor Eight Inhibitor Bypassing Activity, Vapor Heated (FEIBA VH) Decreases Bleeding Frequency and Maintains or Improves Joint Status |
| Leite L |
- |
Effects of Leptospiral Proteins on Human Endothelial Cells |
| Leitner JM |
- |
Anticoagulant and Anti-inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge |
| Leitner K |
- |
Antiapoptotic Activity of Vascular Endothelial Growth Factor (VEGF) Is also Mediated by VEGF Induced Pro-urokinase (Pro-uPA) Activation |
| Leitner JM |
- |
Effects of the Pan-Selectin Antagonist Bimosiamose (TBC1269) on LPS Induced Coagulation |
| Lejniece S |
- |
Twins Pregnancy in the Case of Essential Thombocythemia: A Case Report |
| Lejnieks A |
- |
Twins Pregnancy in the Case of Essential Thombocythemia: A Case Report |
| Lemesle M |
- |
TIIICBP: The Platelet Receptor for Type III Collagen is Present into Platelet Membrane Lipid Microdomains (Rafts) |
| Lemmi A |
- |
Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer |
| Lenato G |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Lenicek Krleza J |
- |
Ischemic Childhood Stroke and Lipoprotein (a) |
| Lenk H |
- |
Use of Helixate®NexGen in the Treatment of Patients with Haemophilia A: A Long-Term Pharmacovigilance Surveillance |
| Lenkowski A |
- |
Hemophilia B Mice Have Delayed Wound Healing |
| Lennemann K |
- |
Detection and Expression of Three Missense Mutations in the Bb Fibrinogen Gene Resulting in A- and/or Hypofibrinogenaemia |
| Lensing AWA |
- |
Outcomes in Obese Patients of Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT) Treatment with Fondaparinux or (LMW) Heparins: The Matisse Trials |
| |
- |
Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis |
| |
- |
Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis |
| |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Lenta R |
- |
PAR1- and S1P Pathway-Dependent Protection of Endothelial Barrier Integrity by Activated Protein C and Thrombin |
| Lenti M |
- |
Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study |
| |
- |
The Contemporary Presence of Elevated Levels of Factor VIII and PAI-1 Is a Risk Factor for Recurrent Thromboembolism. A Retrospective CaseControl Study |
| Lenti L |
- |
Thrombus Growth Is Mediated by Gp91phox |
| Lenti M |
- |
Polymorphisms in Genes Involved in Homocysteine Metabolism in the INCHIANTI Study |
| |
- |
C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation |
| Lenting PJ |
- |
C4b-binding Protein (C4BP) Prolongs the Survival of Human Protein S in an Experimental Mouse Model |
| Lenting PJ |
- |
von Willebrand Factor D'-D3-domains comprise an adhesion site for leukocytes |
| |
- |
Shielding of the A1-Domain by the Amino-Terminal Domain (AA7641035) of von Willebrand Factor Modulates Its Interaction with Platelet Glycoprotein Ib-IX-V |
| |
- |
Platelet Activation by Oxidized Low-Density Lipoprotein Is Mediated by CD36 and Scavenger Receptor-A |
| |
- |
Functional Duplication of Ligand-Binding Domains within Low-Density Lipoprotein Receptor-Related Protein for Interaction with Alpha2-Macroglobulin, Factor IXa and Factor VIII |
| |
- |
C-Terminal Domain of Beta2-Glycoprotein I Is Involved in Binding to Apoer2' |
| |
- |
Genetic Defects of von Willebrand Factor as a Determinant of Its Survival in the Circulation |
| |
- |
Distinct Roles of Basic Residues within the Heparin-Binding Exosite of Factor IX in the Assembly of the Factor X-Activating Complex |
| |
- |
Interaction of Beta2-Glycoprotein I with Members of the Low-density Lipoprotein Receptor (LDLR) Super Family |
| |
- |
Active Von Willebrand Factor Is present in Plasma of Patients with Von Willebrand Disease Type 2B Or ADAMTS-13 Deficiency |
| Lentz SR |
- |
Mechanisms of Homocysteine-Induced Atherothrombosis |
| Lentz SR |
- |
Decreased Protein C Activation and Accelerated Thrombosis in Human Thrombomodulin Knockin Mice |
| |
- |
Oxidant Signaling as a Mediator of Platelet Procoagulant Activity and Coated Platelet Formation |
| Lentz S |
- |
A Missense Mutation in Exon 28 (C4120T) of the Von Willebrand Factor Gene is the Cause for Von Willebrand Disease in a Large Amish Pedigree |
| León A |
- |
Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution |
| Leon MB |
- |
Transendocardial Autologous Bone Marrow Cell Transplantation in Patients with Advanced Ischemic Heart Disease A Multi-Center Feasibility Study |
| Leon C |
- |
Interaction of Calmodulin with the Platelet ADP Receptor P2Y1 |
| Leone G |
- |
Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants |
| Leone M |
- |
Different Patterns of Release of the Soluble Form of the Endothelial Protein C Receptor in Critically Ill Patients |
| |
- |
Platelets Release Matrix Metalloproteinases in the Coronary Circulation of Patients with Acute Coronary Syndromes |
| |
- |
Detection of a Critical Degree of Platelet TxA2-Production Inhibition by the PFA100 in Aspirin-Treated Subjects: Possible Relevance for the Monitoring of Aspirin Resistance |
| Leone M |
- |
Evidence Suggesting That Activated Platelets Induce APC-Resistance in Vivo |
| Leong W |
- |
Biochemical and Pharmacological Equivalence of Generic Versions of Low Molecular Weight Heparins. A Comparative Study with Innovator Products |
| Leong H |
- |
The Effect of Thrombin Concentration on Fibrin Clot Structure Imaged by Multiphoton Microscopy and Quantified by Fractal Analysis |
| Leong K |
- |
Non-Viral Gene Delivery for Treatment of Haemophilia a in Mice: Assessment of Low Factor VIII Levels Using a Fluorogenic Thrombin Generation Test (FTGT) |
| Leong HS |
- |
Imaging of Highly Organized Vitronectin-Vimentin Polymeric Complexes that Express on the Surface of Activated Platelets and Platelet Microparticles using Atomic Force Microscopy |
| |
- |
Chimeric PAI-1-dsRed Fusion Protein Characterization and Expression in MEG-01 Megakaryocytic Cells: Model for PAI-1 Trafficking from a-Granules to Cell Surfaces |
| Leor J |
- |
Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice |
| Lepage S |
- |
Marginal Effect of Interference of Simvastatin on Clopidogrel Antiplatelet Effectiveness Assessed by Measures of Platelet Activation and Aggregation |
| Lepäntalo A |
- |
Limited Antiplatelet Effect of Clopidogrel In Aspirin-treated Patients with Coronary Artery Disease Associates with Cardiac Endpoints |
| Leporini E |
- |
eNOS Gene Affects Blood Viscosity and Red Cell Deformability: Role of eNOS T-786C, G894T and 4a/4b Polymorphisms |
| Lequerrec A |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| Lerma MA |
- |
Mutational Spectrum of Severe Hemophilia A in A Reference Congenital Coagulopathies Unit: Detection of New Molecular Defects |
| |
- |
Molecular Studies in Patients with Type 3 and Type 1 Von Willebrand Disease. New Candidate Mutations |
| Leroyer C |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Diagnostic Value of D-Dimer Assay in Patients with Suspected Pulmonary Embolism: Results in a Multicentre Outcome Study, the ESSEP Study (Evaluation du Scanner Spiralé dans l'Embolie Pulmonaire) |
| |
- |
Recurrent Venous Thrombo-Embolism in Cancer Patients: Data from a Hospital-Based Case-Control Study |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| |
- |
Effect of Age on the Performance of a Diagnostic Strategy Based on Clinical Probability, Spiral CT and Venous Compression Ultrasonography: The ESSEP Study |
| |
- |
Deep Venous Thrombosis in Patients with Acute Pulmonary Embolism: Prevalence, Risk Factors and Clinical Significance |
| |
- |
Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Drug Use and the Risk of Venous Thromboembolism: Results of an Ongoing Hospitalized-Based CaseControl Study |
| |
- |
Age May Modify the Relationship Between Factor V Leiden Mutation: but not G20210A Prothrombin Gene Variation: and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study |
| |
- |
Is It Safe to Withhold Anticoagulant Therapy in Patients with Negative Results on Spiral CT Pulmonary Angiography? |
| Leser PG |
- |
Frequency of Anticardiolipin (aCL) Antibodies in Patients with Lupus Anticoagulant (LA) Detected by Different Methods: An Analysis of 4265 Cases |
| Lester W |
- |
In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study |
| Lester Z |
- |
Unique Patient Pathway for a Nurse-led DVT Clinic |
| Lester W |
- |
Molecular Pathogenesis of Type 1 von Willebrand Disease (VWD) A UK National Study |
| LesterO'Connor WNTJ |
- |
Pseudo von Willebrand Disease: 2B or not 2B? Cryoprecipitate Induced Platelet Aggregation Solves Hamlet's Dilemma |
| Lethagen S |
- |
A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study |
| |
- |
Supplementation with Folic Acid or Vitamin C and E in Patients with Bleeding Disorders and Hepatitis C Treated with Pegylated Interferon and Ribavirin |
| |
- |
Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects |
| |
- |
Long-term Prophylaxis in VWD. The Swedish Experience |
| Lethagen S |
- |
The Prevalence of Low von Willebrand Factor Activity and von Willebrand Disease Among Young Women with Bleeding Symptoms |
| Lethagen S |
- |
The Haplotype Structure of the von Willebrand Factor (VWF) Gene Promoter Indicates Balancing Selection |
| |
- |
Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study |
| |
- |
Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study |
| |
- |
In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study |
| |
- |
Genetic Variation of VWD Type I in Sweden: Tracing the Evolutionary History of the von Willebrand Factor Gene Region |
| Lethagen S |
- |
Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD |
| Lethagen S |
- |
Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study |
| Lethagen S |
- |
Treatment of Chronic Hepatitis C Infection in Patients with Hemophilia or Von Willebrand Disease with a Combination of Pegylated Interferon and Ribavirin |
| Lethagen S |
- |
Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD |
| |
- |
Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study |
| |
- |
Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study |
| |
- |
Cys570Ser Mutation in the von Willebrand Factor Propeptide in Recessive von Willebrand Disease |
| |
- |
Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD) |
| |
- |
Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype |
| |
- |
The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study |
| Lethagen LS |
- |
The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project |
| LethagenZöller SB |
- |
Co-segregation of the PROS1 Locus and Protein S Deficiency in Families having no Detectable Mutations in PROS1 |
| Letourneur D |
- |
Modulation of Protease Nexin-1 Activity by Polysaccharides |
| Letowska M |
- |
Severe Hemophilia in Poland Focus on Hemophilic Arthropathy |
| Letsas K |
- |
How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals? |
| Leung R |
- |
Detection of Platelet Dense Granule Deficiency in Pediatric Patients by Quantitative Electron Microscopy |
| Leung LLK |
- |
Structural Requirements for the Inhibition of Thrombin by Protein C Inhibitor in the Absence and Presence of Heparin and Thrombomodulin |
| |
- |
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Regulates Activated Complement C5a in vivo |
| |
- |
Molecular Characterization of Plasminogen Activator Inhibitor-1 (PAI-1)/Thrombin Inhibition in the Absence and Presence of Heparin and Vitronectin (VN) |
| Leurs J |
- |
A Novel Coupled Enzymatic Assay for the Fast Kinetic Characterization of Synthetic and Physiological CPU (TAFIa) Substrates |
| |
- |
Plasma proCPU (TAFI) Concentrations and Clot Lysis Time Are Not Different in a Chilean Population of Young Healthy Individuals Subgrouped According to the Naturally Occurring 325 Thr/Ile Polymorphism |
| |
- |
Patients with Mucocutaneous Bleeding and Hereditary Disorders of Primary Haemostasis Have Higher Plasma proCPU Levels But a Similar Distribution of the 325 Thr/Ile Polymorphism Compared to Age and Sex Matched Healthy Controls |
| Levashov MY |
- |
Inhibition Kinetics of Plasmin-staphylokinase (Pm-STA) and Plasmin-Streptokinase (Pm-SK) Complexes with Different Protein Inhibitors |
| Levels JHM |
- |
SELDI-TOF MS: A Potential High-Throughput Tool for High-Density Lipoprotein Analysis |
| Levels JHM |
- |
Proteomic Analysis of High-Density Lipoprotein |
| Levenson J |
- |
Direct Flow Cytometry Counting of Circulating Endothelial Progenitor Cells in Whole Blood and Relationship with Cardiovascular Risk Factors |
| Lévesque H |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| Levesque H |
- |
The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH) |
| Levi M |
- |
Local Attenuation of the Protein C Pathway in Patients Developing Pneumonia |
| |
- |
Acute Hyperglycemia Perturbs Endothelial Glycocalyx and Induces a Prothrombotic State in Healthy Volunteers |
| |
- |
Effects of Clopidogrel on the Rebound Hypercoagulable State in Acute Coronary Syndromes (ACS) Patients after Heparin Discontinuation |
| Levi MM |
- |
Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study |
| Levi M |
- |
Thromboembolic and Bleeding Complications during Non-cardiac Surgery in Patients with Mechanical Heart Valves |
| Levi D |
- |
Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss |
| Levi M |
- |
Sustained Factor VIII and vWF Elevation after Total Hip Arthroplasty |
| |
- |
Endotoxemia Induces Factor VIII-mediated Resistance to Activated Protein C in Healthy Humans |
| |
- |
Lung-Protective Mechanical Ventilation Attenuates Fibrin Generation in Healthy Lungs |
| Levi MM |
- |
The Role of PAI-1 Deficiency and a Reduced Capacity to Generate Activated Protein C on Coagulation Activation and Fibrin Formation during Murine Influenza Pneumonia |
| |
- |
Naturally Occurring Acute Viral Respiratory Tract Infections in Elderly Patient Results in Increased von Willebrand and Enhanced Fibrinolysis |
| Levine RL |
- |
Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia |
| Levine RL |
- |
Heparin Antibodies in Intensive Care Unit Patients (The HAICU Study) |
| |
- |
Venous Thromboembolism in Heparin-Treated Patients: How Frequently Is It Associated with Heparin-Induced Thrombocytopenia? |
| Levinskaya N |
- |
The Platelet/Endothelial Cell Adhesion Protein F11R (a.k.a. JAM-1) Is Present in Cerebral Blood Vessels, Meninges, the Choroid Plexus and on Neuronal Cells |
| Levitskiy I |
- |
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions |
| Levrat A |
- |
Usefulness of Thromboelastography (ROTEM®) in Coagulation Management in Trauma Patient |
| Levy G |
- |
An Endothelial Cell-specific Regulatory Mutation In Galgt2 Is the Major Cause of Prolonged aPTT in Mice |
| Levy-Shraga Y |
- |
Platelet Function of Preterm and Full Term Newborns Tested by The Cone and Plate(let) Analyzer Correlates with Gestational Age |
| Lew R, Fiore |
- |
Inflammation and Venous Thromboembolism in Hospitalized Medical Patients |
| Lewandrowski U |
- |
An Approach to Elucidate the Platelet Membrane Proteome |
| Lewandrowski U |
- |
Glycosylation Site Analysis of Human Platelet Proteins |
| Lewis BE |
- |
Effects of the Direct Thrombin Inhibitor Argatroban, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia |
| Lewis H |
- |
Intravenous DDAVP Associated Reduction in Fibrinogen Implications for Patients with Von Willebrand's Disease or Haemophilia A with Borderline Fibrinogen Levels Requiring Invasive Procedures |
| |
- |
Introduction of Thromboelastography for Monitoring Haemostatic Function during Pseudomyxoma Peritonei Surgery |
| Lewis D |
- |
Measurement of Platelet Function in Response to 3 Common Antiplatelet Regimens in Patients with Peripheral Occlusive Arterial Disease (POAD) |
| Lewis BE |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| Leya F |
- |
Platelet and Inflammatory Alterations Associated with Late Restenosis in Patients Undergoing Angioplasty and Brachytherapy |
| |
- |
Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis |
| Leyte A |
- |
Pravastatin Reduces Levels of the Glycoprotein IIIa Subunit from the Fibrinogen Receptor on Platelet-Derived Microparticles in Patients with Type 2 Diabetes |
| Leyte A |
- |
The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria |
| Leyte A |
- |
Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism |
| Leytin V |
- |
Regulation of in vivo Viability of Stored Platelet Concentrates by Platelet P-selectin Exposure and Glycoprotein Ib-alpha Downmodulation |
| |
- |
Shear-Induced Platelet Apoptosis |
| Lheureux, Ph, Motte S |
- |
Accuracy of Pretest Probability Assessment of Pulmonary Embolism by Junior Physicians Using the Explicit Wells Clinical Model |
| Li N |
- |
Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk |
| Li N |
- |
Postprandial Hyperglycaemia Induces Platelet Activation in Type 2 Diabetes Mellitus: Effects of Treatment with Repaglinide and Glibenclamide |
| Li Q |
- |
Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients |
| |
- |
Increased Plasma and Platelet Surface Fibronectin in Acute Myocardial Infarction Patients |
| Li S |
- |
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue |
| Li N |
- |
Effects of Oral Hormone Replacement Therapy (HRT) on Platelet Function, Inflammatory Markers and Matrix Metalloproteinases in Postmenopausal Women with Established Coronary Artery Disease |
| Li L |
- |
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family |
| Li K |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Li Y |
- |
Clinical Aspirin Resistance Is Associated with Increased Cyclooxygenase-Independent Platelet Activation |
| Li JC |
- |
Pentoxifylline Protects Rats from Endotoxin-Induced Disseminated Intravasvular Coagulation by Inhibiting the Elevations of TNFa and Tissue Factor |
| Li N |
- |
Platelet-Lymphocyte Conjugation: Different Behavior Between T and B Cells |
| Li SY |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Li Z |
- |
Robustness Testing of OPTIVATE® Intermediate Purification Stages |
| Li N |
- |
Effects of Acute Hyperglycaemia on Platelet and Leukocyte Activation: Involvement of Multiple Mechanisms |
| Li JC |
- |
Changes of Tissue Factor Pathway in Patients with Hypertension and Coronary Heart Disease |
| Li K |
- |
The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice |
| Li CK |
- |
The Effect of Chinese Danggui and PDGF on Thrombopoiesis in Irradiated Mice |
| Li Y |
- |
Pre-Existent Variability in Platelet Response to ADP Accounts FOR Clopidogrel Resistance |
| Li C |
- |
Platelet Function Monitoring by the PFA-100® in Patients Taking Non-Aspirin NSAIDs |
| Li P |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Li N |
- |
Glycoprotein IIb/IIIa Blockade Inhibits Platelet Phosphatidylserine Exposure But Not Vesiculation |
| Li Z |
- |
Adhesion Molecules and Leukocyte Migration in the Context of Corneal Wound Healing |
| Li K |
- |
The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production |
| Li W |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Li R |
- |
Heteromeric and Homomeric Transmembrane Domain Associations Regulate aIIbb3 Function |
| Li N |
- |
Apical Sorting of ADAMTS13 in Madin-Darby Canine Kidney (MDCK) Cells Depends on an Association with Detergent-Insoluble Sphingolipid and Cholesterol-Enriched Rafts |
| Li XF |
- |
Influence of Cinnamic Acid on the Expression of Tissue Factor Induced by Tumor Necrosis Factor a and Its Mechanism in Vascular Endothelial Cells |
| Li N |
- |
Food Intake Enhances Platelet Reactivity to Thromboxane in Type 2 Diabetic Patients |
| Li Vigni M |
- |
Idiopathic Acquired Haemophilia: Two Case Reports with Different Severity of Clinical Manifestation, Both in Rapid Disappearing with Non-Aggressive Immunotherapy |
| Liakopoulou-Kyriakides M |
- |
Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro |
| Liang Z |
- |
The Development of Transplanted Rat Prostate Tumors in vivo Is Impaired by Reduced Tissue Factor Expression |
| Liang Z |
- |
A Novel Role for Maternal Protein C in Embryonic Development |
| Liang HPH |
- |
Functional Analysis of Obligate Heterozygous Defects in Platelet Glycoprotein (GP) Ib-V-IX in Velo-Cardio-Facial Syndrome (VCFS) Patients |
| Liang Z |
- |
Identifying Hemostatic Modifier Loci Ameliorating FVII-Insufficiency Using Phenotypic Differences between Strains |
| Liang W-C |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Liang X |
- |
Factor Va Membrane Binding Affinity and Prothrombinase Activity are Enhanced by Incorporation of Phosphatidylethanolamine into Phosphatidylserine Containing Membranes |
| Liang HPH |
- |
A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia |
| Liao CH |
- |
Disabled-2 Is a Secreted Anti-adhesive Molecule During Platelet Activation and Aggregation |
| Liao CH |
- |
Effect of YC-1, a cGMP-dependent Manner, on Heterotypic CellCell Interaction: The Study on Neutrophil-platelet Adhesion |
| Liao P |
- |
Adjunctive Use of Anticoagulants with a TAFIa Inhibitor Does Not Further Enhance t-PA-Induced Thrombolysis in a Rabbit Arterial Thrombosis Model and Compromises Safety |
| Liao JK |
- |
Activation of NF-kB by Reactive Oxygen Species Mediates Induction of PAI-1 Expression in Vascular Endothelial Cells |
| Liaw P |
- |
Effect of Chemotherapeutic Agents on the Protein C Anticoagulant Pathway |
| |
- |
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant |
| Libby E |
- |
D-dimer Stability of Specimens Stored AT -20 and -70 DEGREES Celsius |
| Libert C |
- |
Deficiency of Matrix Metalloproteinase-2 (MMP-2) Impairs Platelet-Dependent Haemostasis in Mice |
| Libman M |
- |
Thrombophilia Is Not a Risk Factor for Peripheral Intravenous Infusion-Associated Thrombophlebitis |
| Liboni A |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Lichte A |
- |
Performance Evaluation of APC Resistance/FV Leiden Assay Applications on Routine Coagulation Analyzers |
| Lichtin A |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Lieberman ED |
- |
Tissue Factor: Lack of the Cytoplasmic Tail Results in Generation of Functional Microparticle-Associated Tissue Factor |
| Liebetrau C |
- |
Drotregocin Alfa (Activated) Down-Regulates RANTES in Peripheral Blood Mononuclear Cells of Septic Patients In Vivo |
| Lienhart A |
- |
Usefulness of Thromboelastography (ROTEM) for Treatment Management in a Severe Deficiency FXIII Patient with Inhibitor |
| |
- |
Immune Tolerance with FEIBA in a Severe Haemophiliac B with Inhibitor |
| Lieske KA |
- |
Anti-b2 Glycoprotein I (b2GPI) and Anti-Annexin A2 Antibodies Stimulate the Release of Microparticles from Endothelial Cells |
| Lieske B |
- |
In vivo Relevance of Platelets and the Fibrinogen Receptor GPIIb-IIIa for Experimental Melanoma Metastasis |
| Liesner R |
- |
Six Children with Congenital Deficiency of ADAMTS-13: Clinical Features and Treatment |
| Liesner R |
- |
Efficacy, Safety and Pharmacokinetic Properties of ADVATE rAHF-PFM in Previously Treated Patients (PTPs) Less Than 6 years of Age |
| Liesner R |
- |
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A |
| Liestøl S |
- |
Decreased Anticoagulant Response to Recombinant Tissue Factor Pathway Inhibitor (TFPI) in Pooled Normal Plasma with IgG Fractions from Patients with Lupus Anticoagulant is Associated with Increased Thrombin Generation |
| Light DR |
- |
Tissue Factor Targeted Thrombomodulin (Ab(TF)-TM) a Novel Tissue Factor Neutralizing Antibody Fused to Thrombomodulin (TM) |
| Light D |
- |
Inhibition of Thrombosis after Vascular Injury with a Novel Tissue Factor-Targeted Thrombomodulin Fusion Protein |
| Light DR |
- |
Tissue Factor-Neutralizing Antibody Fused to Thrombomodulin (Ab(TF)-TM) Has Amplified Anticoagulant Efficacy in a Rat Model of Thromboembolism |
| Lihacheva EA |
- |
Diagnosis and Treatment of Von Willebrand's Disease |
| Lijnen HR |
- |
Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity |
| Lijnen R |
- |
Role of the Fibrinolytic System in the Development of Obesity and the Metabolic Syndrome |
| Lijnen HR |
- |
Endogenous Tissue-Type Plasminogen Activator Is Essential for an Adequate Host Defense During  Induced Abdominal Sepsis |
| |
- |
Lipopolysaccharide-Induced Endotoxemia in the Mouse is Aggravated by PAI-1 Overexpression |
| Lijnen HR |
- |
Role of the Matrix Metalloproteinase System in Adipose Tissue Development |
| Lillicrap D |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| |
- |
Prevention of Anti-FVIII-C2 inhibitor formation Post Protein infusion in Hemophilic Mice By Prior Oral and/or Nasal Exposure of the FVIII-C2 Domain |
| |
- |
A Case of Non-Resolving Hemophilia B Leyden in a 40 year Old Male (Factor IX promoter +13 A to G) |
| |
- |
Anti-FVIII Inhibitor Development in Hemophilic Mice is Dependent Upon Genetic Background, Adjuvant Type, Injection Site, and Frequency of Antigen Exposure |
| |
- |
A Pilot Study of a DNA Microarray-Based Approach for the Screening of Mutations in Hemophilia A |
| |
- |
Characterization of Recombinant Canine Factor VIII and Quantitative Determination of Factor VIII in Canine Plasma |
| |
- |
Disruption of an Immunogenic Epitope in the FVIII C2 Domain Results in the Prevention of Anti-FVIII-C2 Inhibitor Formation in BALB/c-FVIIIKO Hemophilic Mice |
| |
- |
In Vitro Stability of Dilutions of the Recombinant Factor VIII Kogenate FS for Continuous Infusion Use |
| |
- |
Cross-over Comparative Study of Tolerability, Pharmacokinetics and Efficacy of Two Forms of Porcine Factor VIII in the Canine Model of Hemophilia A |
| Lillis AP |
- |
Beyond Endocytosis: LRP Function in Cell Migration, Proliferation and Vascular Permeability |
| Lim B |
- |
Atomic Force Microscopy Imaging of Fibrinogen on Different Surfaces: Implications for Implantation Materials Design |
| |
- |
Atomic Force Microscopy Imaging of Blood Coagulation Factor XIII in Its Native Form and in Fibrin Clot Formation |
| Lim Y |
- |
The Antiplatelet Activity of Hesperetin Is Mainly Mediated By Inhibition of PLCg2 Phosphorylation and Its Downstream Signal Transduction |
| Lim KT |
- |
Possible Interactions between Prion Protein and Transglutaminase: Irreversible Cross-Linking of Prion Protein to Fibrinogen by Factor XIIIa |
| Lim HS |
- |
Angiopoietin-1 and Angiopoietin-2 in Diabetes Mellitus: Relationship to VEGF, Glycaemic Control, Endothelial Damage/Dysfunction and Atherosclerosis |
| Lim Y |
- |
Inhibitory Effect of Luteolin on the PDGF-Induced Proliferation of Rat Aortic Vascular Smooth Muscle Cells |
| Lima LM |
- |
Increased Plasma Levels of Lipoprotein(a) Correlate with Severity of Angiographically Defined Coronary Artery Disease |
| Limburg V |
- |
An Antibody Fragment Against Factor VIII That inhibits Factor VIII assembly with von Willebrand Factor and LDL Receptor Family Members |
| Lin CW |
- |
Complete Subunit Sequences and Glycan Structures of Factor X Activator from Russell's Viper Venom |
| Lin JS |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Lin CY |
- |
Genetic Frequencies of Single Nucleotide Polymorphisms in Predisposition to a Hypercoagulable State in Taiwan |
| Lin L |
- |
Differentiation of Telomerase-Expressing Endothelial Cells Progenitors Derived from Adipose Tissue |
| Lin R |
- |
The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia |
| Lin H-Y |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Lin B |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Lin J-S |
- |
An Unusual Clustering of S1506Lmutation in Type 2A von Willebrand Disease Seen in Taiwan |
| Lin S-R |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Lin S-W |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Lin JS |
- |
Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels |
| Lin C-n |
- |
Characterization Of Factor IX With Mutations At Residues 190 And 192 Of The Heavy Chain Of Defective Factor IX Found In Patients With Hemophilia B |
| Linardi CCG |
- |
Treatment of Extensive Venous Malformation-Associated Localized Intravascular Coagulation with Interferon-Alpha: Case Report |
| Linares ME |
- |
Acquired Antithrombin Deficiency in Acute Lymphoblastic Leukaemia (ALL) Induced by L-Asparaginase (ASNase): A Conformational Mechanism Modulated by Dexamethasone |
| Linari S |
- |
Long Term and Low Dose Prophylaxis with rFVIIa in Patients Affected by Congenital Bleeding Disorders |
| Lindahl TL |
- |
Video Enhanced Coagulation Assay (VECA) for Real Time Multi-Parameter Analysis of Blood Plasma Coagulation at Artificial Surfaces |
| Lindahl TL |
- |
The Platelet Contribution to Elastic Properties of Blood and Plasma Clots Differences in Measuring Range between FOR and ROTEM |
| Lindahl B |
- |
Elevated Levels of Interleukin-10 and the IL-10 -819 C/T SNP Are Predictors of Poor Prognosis in Patients with Acute Coronary Syndrome |
| Lindahl AK |
- |
Markers of Vascular Inflammation Are Associated with the Degree of Atherosclerosis Assessed as Angiographic Score and Treadmill Walking Distance in Patients with Peripheral Arterial Occlusive Disease |
| Lindahl TL |
- |
Whole Blood Clotting Time in the Presence of the Platelet PAR-1 Activating Peptide TRAP-6 Predicts Post-operative Bleeding in Open-heart Surgery A Pilot Study Utilizing Free Oscillation Rheometry |
| Lindahl B |
- |
Interleukin-18 Predicts Long-term Mortality in Patients with Non-ST Elevation Acute Coronary Syndrome |
| |
- |
The -3459 A > GSNP in the CD40L Gene Predicts Plasma Concentrations and Outcome in Patients with Acute Coronary Syndrome (FRISC-II) |
| Lindahl TL |
- |
Prothrombin Complex Methods Are Most Sensitive for Prothrombin, Less for Factor VII and Much Less for Factor X, But the Contribution of the Different Factors, Vitamin K Dependent and Non-dependent Factors, Varies a Lot between Reagents |
| |
- |
Characterisation If Species Differences in the Platelet Thrombin/ADP Response |
| Lindahl T |
- |
Plasma Warfarin and The Ratio of S- and R-Enantiomers in Patients Correlated to the International Normalized Ratio |
| Lindblad B |
- |
Prevalence and Risk of Pulmonary Embolism in Patients with Intracardiac Thrombosis. A Population-Based Study |
| Linde R |
- |
Antiidiotypic Single Chain Fragments Specific for Inhibitors to Coagulation Factor VIII Isolated by Phage Display Screening of Polyclonal Haemophilia a Patient's Plasma |
| |
- |
Epitope Mapping During FVIII Inhibitor Eimination With Rituximab Reveals Conformational Epitopes on FVIII and Identifies Small Molecules Blocking Inhibitor and Targeting B Cells |
| |
- |
Screening of Phage Displayed Random Peptide Libraries Reveals Conformational Epitopes of Inhibitors in a Haemophilia B Patient |
| Lindeman R |
- |
Successful Treatment of a High Titre Factor VIII Inhibitor with Rituximab Alone |
| Linden MD |
- |
Preconditioning Ischemia Favorably Attenuates Platelet Activation: Insights into Molecular Mechanisms |
| Linden MD |
- |
Pre-Existent Variability in Platelet Response to ADP Accounts FOR Clopidogrel Resistance |
| |
- |
Clinical Aspirin Resistance Is Associated with Increased Cyclooxygenase-Independent Platelet Activation |
| Linden MD |
- |
A Novel Mechanism of Action of Clopidogrel: Inhibition of Monocyte Procoagulant Activity |
| |
- |
Factor V Leiden and Aprotinin in Cardiopulmonary Bypass |
| |
- |
Increased Platelet Activation in Cystic Fibrosis: A Role for cAMP/Adenylate Cyclase But Not for Mead Acid or Platelet CFTR |
| Lindgren L |
- |
Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation |
| Lindhoff-Last E |
- |
Thrombophilia in Inherited Antithrombin Deficiency |
| |
- |
Prevalence of Acquired and Hereditary Thrombophilic Disorders in Women with Pregnancy Loss |
| |
- |
Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium |
| |
- |
Genetic variants in COX 1-, GP Ia/IIb- and FXIIIa-subunits: Effects on Response to Aspirin in Patients with Peripheral Arterial Occlusive Disease |
| |
- |
Monitoring of Aspirin and Clopidogrel Response in Patients with Arterial Occlusive Disease with Different Platelet Function Methods |
| |
- |
Rebound after Discontinuation of Long-term Oral Anticoagulation (OAC): Effects of a 4 week Course of LMWH on VTE Recurrences |
| |
- |
Prevalence and Clinical Significance of Anti-b2-Glycoprotein-I-Antibodies in Patients with Venous Thrombosis |
| |
- |
Use of Native or Platelet Count Adjusted Platelet-Rich Plasma for Platelet Aggregation Measurements |
| Lindhoff-Last E |
- |
Treatment of 51 Pregnancies with Danaparoid Because of Heparin Intolerance |
| Lindhoff-Last E |
- |
Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis |
| Lindhout T |
- |
Down-regulation of Tissue Factor Surface Expression by Annexin A5: a New Anticoagulant Mechanism |
| |
- |
Real-Time in Vivo Imaging of the Kinetics of Macrovascular Thrombus Formation |
| |
- |
Platelet Derived Microparticles in Blood Bank Products Do Not Expose Functionally Active Tissue Factor But Are Highly Procoagulant |
| |
- |
Apoptosis of Monocytes Reduces Their Interaction with P-Selectin Expressing Platelets Under Flow Conditions by Disruption of the Interaction of PSGL-1 with the Actin Cytoskeleton |
| |
- |
Phosphatidylserine Exposure During Platelet Stimulation Is Caused by Activation of Scramblase and Inactivation of Aminophospholipid Translocase in a Distinct Platelet Fraction |
| |
- |
Intracellular PAR Antagonists Have Anticoagulant and Antithrombotic Properties |
| Lindmarker P |
- |
Prospective Evaluation of Low PAI-1 Activity as a Risk Factor for Hemorrhagic Diathesis |
| Lindner T |
- |
Venous Thromboembolism: Involvement of ADAMDEC1 Polymorphisms in Familially High Factor VIII Levels |
| Lindqvist A-K |
- |
Platelet Function Analyzer (PFA-100R) Detects Intranasal Desmopressin Responses in Patients with Hemophilia A and von Willebrand Disease |
| Ling M |
- |
A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence |
| Linkins LA |
- |
Proportion of Major Bleeds That Are Intracranial or Fatal According to Indication for Oral Anticoagulant Therapy |
| Linn T |
- |
Factor VII Activating Protease (FSAP) Inhibits Angiogenesis in vivo |
| Linné R |
- |
Home Treatment in Pulmonary Embolism |
| Lip GYH |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| |
- |
Analysis of Combination Anti-Angiogenesis Therapy on Markers of Coagulation, Platelet Activation and Angiogenesis in Patients with Advanced Cancer |
| |
- |
Circulating Endothelial Cells in Acute Ischaemic Stroke |
| |
- |
Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty |
| |
- |
Angiopoietin-1 and Angiopoietin-2 in Diabetes Mellitus: Relationship to VEGF, Glycaemic Control, Endothelial Damage/Dysfunction and Atherosclerosis |
| |
- |
Plasma Levels of Tissue Factor and Soluble E-Selectin in Sickle Cell Disease: Relationship to Genotype and to Inflammation |
| |
- |
Increased Circulating Endothelial Cells in Acute Congestive Heart Failure: Comparison with von Willebrand Factor and Soluble E Selectin |
| Lischetzki G |
- |
High Titre Inhibitor in a Paediatric Haemophilia B Patient |
| Lischetzki G |
- |
Living with Morbus Glanzmann A Case Report of a Now 20 Year Old Mother |
| Lisco P |
- |
Should Asymptomatic Children with Hereditary Haemorrhagic Telangiectasia (HHT) Be Screened for Vascular Malformations? |
| Lisenko L |
- |
Endotheliumdependent Factors of Haemostasis and Fibrinolysis in Some Renal Diseases |
| Lisi F |
- |
Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures |
| Lisi R |
- |
Hypercoagulability May Predict Embryo Implantation after Assisted Reproductive Procedures |
| Lisman T |
- |
Glycoprotein Iba-Mediated Platelet Adhesion and Aggregation to Immobilized Thrombin under Conditions of Flow |
| |
- |
C4b-binding Protein and the Risk of Venous Thrombosis |
| |
- |
Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families |
| |
- |
Highly Elevated Levels of Von Willebrand Factor in Patients with Liver Cirrhosis Support Platelet Adhesion Despite Its Reduced Functional Capacity |
| |
- |
Increased Fibrinolytic Activity in Patients with a More Severe Clinical Phenotype of Severe Hemophilia A |
| |
- |
Platelet Adhesion to Dimeric Beta2-Glycoprotein-I Under Conditions of Flow Is Mediated by Glycoprotein Iba |
| Lisowska A |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG) |
| Lisowski P |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Stable Angina Pectoris Patients Undergoing Coronary Artery Bypass Grafting (CABG) |
| Lissalde-Lavigne G |
- |
The Factor V Leiden and Prothrombin 20210G>A Mutations as Risk Factors for Miscarriage during the First Pregnancy: The Matched CaseControl Big NOHA First Study |
| Lissitchkov T |
- |
Treatment of Congenital Coagulation Disorders in Countries with Limited Financial Resources Bulgarian Experience |
| Lissitchkov T |
- |
Immunate S/D Results of a Phase III, Prospective, Multicenter Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Efficacy of Immunate Solvent Detergent in Previously Treated Patients with Severe or Moderately Severe Hemophilia A |
| Littlewood TD |
- |
Apoptotic Mechanisms Underlying High-Risk Plaque |
| Litvinov RI |
- |
Kinetics of Fibrinogen Binding to aIIbb3 Binding Studied at the Single Molecule Level Using Optical Tweezers |
| Liu JW |
- |
Isolation, Characterization and Angiogenic Potential of Human Mesenchymal Stem Cell-Derived Endothelial-Like Progenitor Cells |
| Liu J |
- |
A Novel Anti-LIBS mcAb (3C7) Is Specific for the Complex of Integrin aIIbb3 and Inhibits Platelets Aggregation and Adhesion |
| Liu Y-f |
- |
Carrier Detection and Prenatal Diagnosis on Hemophilia |
| Liu X-f |
- |
Carrier Detection and Prenatal Diagnosis on Hemophilia |
| Liu F |
- |
Identification of Two Novel Mutations in ADAMTS13 Gene in A Pregnant Patient with Congenital Thrombotic Thrombocytopenic Purpura |
| Liu F |
- |
A2 Domain of Human Von Willebrand Factor Expressed in E. Coli and Its Use in Quantitative Measurement of ADAMTS13 Activity |
| Liu S-L |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Liu R |
- |
Evidence of a Critical Role for F11R (a.k.a. JAM-1) in the Adhesion of Platelets to the Endothelium at the Onset of Inflammatory Thrombosis |
| Liu B |
- |
The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo |
| Liu X |
- |
A Peptide Derived from Cytomegalovirus Reverses Antiphospholipid-Mediated Thrombosis by Displacing Binding of b2glycoprotein I to Endothelial Cells in Mice |
| Liu AG |
- |
The Role of Serotonin and Melatonin on Hematopoiesis and Platelet Production |
| Liu B |
- |
High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells |
| Liu CZ |
- |
The Antithrombotic Effect of the Fibrinogen-Binding Fragment of Staphylococcus Aureus Clumping Factor A |
| Liu X |
- |
Induction of Tolerance to b2Glycoprotein I in Mice |
| Liu J |
- |
Genetic Manipulation of Megakaryocytes to Study Platelet Integrin Regulation |
| Liu X |
- |
A Monoclonal Anti-C5 Antibody Reverses Antiphospholipid Antibody-mediated Thrombosis |
| Liu XF |
- |
Molecular Pathology of Haemophilia B in 19 Unrelated Han's Patients: Identification of Five Novel Mutations |
| Liu J |
- |
Prourokinase Activation Is the Speed-limited Step of Its Catalyzed Plasminogen Activation |
| Liu F |
- |
A Novel Deletion Mutation of Von Willebrand Factor Associated with Type 3 Von Willebrand Disease |
| Liu HB |
- |
Amiloride Inhibits Urokinase Type Plasminogen Activator-Mediated Proteolytic Activity and Increases Plasminogen Activator Inhibitor Type-1 mRNA Expression in Aortic Vascular Smooth Muscle Cells |
| Liu X |
- |
Toll Like Receptor 4 Is Involved in Antiphospholipid-mediated Thrombosis: In vivo Studies |
| Liu J |
- |
Thrombin Modulates Proangiogenic Cytokine Secretion and Cell Adhesion of Human Prostate Cancer Cells Via PAR-1 |
| Liu MY |
- |
Hydrogen Peroxide Activation of Platelet-Derived Growth Factor D-chain Transcription Is Mediated by the Winged Helix-Turn-Helix Protein Ets-1 and its Interplay with Sp1 |
| Liu QF |
- |
The Detection of the Platelet Activation by Flow Cytometry in the Patients with Pre-eclampsia |
| Liu K |
- |
Regulation of Human Endothelial Cell Protein C Receptor (hEPCR) Gene Expression |
| Liu JW |
- |
Characterization of Human Endothelial Progenitor Cells Under Various Flow Conditions |
| Liu J |
- |
Factor V Leiden as a Modifier of the Severe Hemophilia Phenotype in Murine Models |
| Liu Y-L |
- |
Factor V Leiden as a Modifier of the Severe Hemophilia Phenotype in Murine Models |
| Liu JW |
- |
Lentiviral Vector-Mediated A20 Gene Transfer to Generate Endothelial (Progenitor) Cells that are Resistant to Inflammatory Stimuli |
| Liu E |
- |
Antithrombotic Activity of a Small Molecule Factor XIa Inhibitor in Rats with Limited Effects on Bleeding Time |
| Livnat T |
- |
Concomitant Infusion of Low Doses of rFVIIa and FEIBA in Severe Hemophilia A Patients with an Inhibitor to Factor VIII Who Are Refractory to rFVIIa or FEIBA Has an Excellent Hemostatic Effect and Synergistically Enhances Thrombin Generation |
| |
- |
Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice |
| Livnat T |
- |
Mechanisms of Thrombin Generation Induced by High Concentrations of Recombinant Factor VIIa |
| Lizka Hackzell J |
- |
Principal Component Analysis to Evaluate Aprotinin Treatment in Abruptio Placentae Patients with Severe Bleeding |
| |
- |
Presentation of Laboratory and Sonoclot Variables Using Principal Component Analysis: Identification of Hypo- and Hypercoagulation in the HELLP Syndrome |
| Ljung RCR |
- |
Novel Mutations in the Factor VIII Gene in Sweden |
| Ljung R |
- |
Risk Factors for Venous Thrombosis in Swedish Children and Adolescents |
| Ljung RCR |
- |
Inhibitor Development and Treatment in Children |
| Ljung R |
- |
Quality of Life in Patients with Haemophilia An European Comparison Study (ESCHQoL) |
| Ljung RCR |
- |
Functional Analysis of the Factor Ix Egf-Like Domain Mutation Ile66thr Associated with Mild Hemophilia B |
| Ljungqvist M |
- |
A Normal D-dimer and a Low Clinical Probability Test Safely Excludes Venous Thromboembolism. A Follow-up D-dimer Adds No Further Information |
| Llorente-Cortés V |
- |
Statins Prevent the Increase of Tissue Factor Activity and Microparticle Release Induced by Aggregated LDL in Human Vascular Smooth Muscle Cells |
| Lloyd J |
- |
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective |
| Lloyd JV |
- |
Kinetics of Factor VIII Assays in Mild Haemophilia A: Implications for Choice of Diagnostic Assay |
| Lloyd J |
- |
Robustness Testing of OPTIVATE® Intermediate Purification Stages |
| Lloyd JV |
- |
A High Prevalence of Ankle Arthropathy in Mild and Moderate Haemophilia A in South Australia and a Threshold Effect of FVIII Level on Its Occurrence |
| |
- |
Accuracy of a Whole Blood D-Dimer Assay (SimplifyTM) for Deep Vein Thrombosis, When Performed Using Venous Whole Blood and Frozen Plasma in a Cohort Patients with Suspected Deep Vein Thrombosis |
| |
- |
FXI Deficiency in South Australia: Diversity of Causative Mutations within a Small Group of Affected Individuals |
| Lloyd J |
- |
Towards Harmonisation of D-dimer Assays |
| Lloyd JV |
- |
The Accuracy of the Wells Pretest Probability Assessment Model for Proximal Deep Vein Thrombosis When Applied by Emergency Department Doctors in South Australia |
| Lämmle B |
- |
Thrombotic Thrombocytopenic Purpura |
| Lo B |
- |
Alpha Granule formation in Megakaryocytes and Platelets Requires VPS33B, A Member of the Sec1/Munc18 (SM) Protein Family |
| Lo M |
- |
An Early-Activated Gene (6A3-5) Implicated in the Control of Vascular Smooth Muscle Cell Functions |
| Lo PC |
- |
Differential Effects of a Glycoprotein Ib Binding Protein, Echiquatin, on Platelet Function in vitro and in vivo |
| Lo K |
- |
The Diagnosis and the Estimated Incidence of Heparin-Induced Thrombocytopenia in the Critically Ill According to ISTH SSC Criteria |
| Lo Coco L |
- |
Thrombophilia in Women with Unexplained Fetal Loss |
| |
- |
Successful Treatment of Acquired Haemophilia with FEIBA® and Retuximab® |
| |
- |
Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors |
| Lobanova ES |
- |
Computer Simulation Model of Spatial Dynamics of Fibrin Clot Growth Under Conditions of Blood Flow |
| Lobo JL |
- |
Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry |
| Lockhart E |
- |
Reaction of Fibrinogen with Homocysteine Thiolactone Renders the Resulting Fibrin Clots Resistant to Lysis |
| Lockstadt H |
- |
Safety, Immunogenicity, and Efficacy of Recombinant Human Thrombin as a Topical Surgical Hemostat: Integrated Results for a Multi-Surgery Phase 2 Program |
| Lockyer S |
- |
GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism |
| |
- |
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization |
| Lodigiani C |
- |
Homocysteine Plasma Levels and MTHFR Genotype in Patients with Retinal Vein Occlusion |
| Lodigiani C |
- |
Relationship between CYP2C9 and VKORC1 Polymorphisms and Anticoagulant Dose Requirement |
| Lodzinska J |
- |
Biochemical Predictors of One-Year Total Mortality in Unselected Acute Coronary Syndromes Patients Treated according to Contemporary Guidelines |
| Loeckermann S |
- |
Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays |
| Loeffler C |
- |
Polymorphisms Known to Increase the Risk of Atherothrombosis Do Not Affect the Risk of Thrombembolism as Determined in Patients with Atrial Fibrillation |
| Loh S |
- |
Effect of Alcohol on Intracellular PH in Human Umbilical Cord Blood CD34+ Stem Cells |
| Loirat C |
- |
Molecular Basis of MYH9-Related Disorders in a Series of Ten Families |
| Lok C |
- |
Microparticle-associated P-selectin Is a Marker of Platelet Activation in Preeclampsia |
| |
- |
Microparticles From Preeclamptic Patients Do Not Affect Transcription of Inflammation-related Genes in Endothelial Cells |
| Lokajczyk A |
- |
Low Molecular Weight Fucoidan Potentiates the Growth Factor-Induced Tube Formation By Endothelial Progenitor Cells |
| Lokar L |
- |
Comparison of Ivy Bleeding Time (BT) and PFA-100 Closure Time (CT) in Hospitalised Patients |
| |
- |
Heparin Induced Thrombocytopenia (HIT) with Thrombosis Case Report |
| Lokhorst HM |
- |
Binding of Amyloid to the Fibronectin Type I Domain of tPA And Factor XII Induces Activation of the Fibrinolytic System and the Contact System |
| Lokken TG |
- |
Congenital Platelet ADP Receptor (P2Y12) Deficiency: A Case Report |
| Lollar P |
- |
Characterization of Anti-Human and Anti-Porcine Factor VIII Monoclonal Antibodies Produced by Hemophilia A Mice |
| Lombardi AM |
- |
Mutations in Homozygotes and Compound Heterozygotes with FXII Deficiency |
| Lombardi R |
- |
Role of Chloride Ions in the Modulation of the Interaction between von Willebrand Factor and Adamts-13 |
| Lombardi A |
- |
Acute Myocardial Infarction in Haemophillia A or B Patients: A Cardiological Evaluation of 44 Reported Cases |
| |
- |
High Rate of Non Responders to Aspirin and/or Clopidogrel Treatment in the First Days Following Percutaneous Coronary Interventions: An Ex Vivo Study |
| Lombardi AM |
- |
High Prevalence of Cardiac Abnormalities in Patients with Congenital FV Deficiency |
| Lombardi A |
- |
Inherited and Acquired Thrombophilic Risk Factors in Atherosclerotic Disease |
| Lombardi R |
- |
Low Plasma Levels of Vitamin B6 and Recurrent Venous Thrombosis: Risk Assessment and Effect of Combined Vitamin Supplementation in the VITRO-Trial |
| Lombardi A |
- |
Antiaggreganting Agents Do Not Influence the Sonoclot Profile |
| |
- |
Non-Catheter Induced Venous Thrombosis in Haemophellia A E B Patients |
| Lombardini D |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| Lombardo D |
- |
Role of the Bile Salt Dependent Lipase (BSDL) in Thrombus Formation: in vitro and in vivo Study |
| Lombino F |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Loncar R |
- |
Experimental Hyperhomocysteinemia Has No Significant Effect on Global Hemodynamics or Regional Myocardial Blood Flow |
| |
- |
Endogenous Myocardial FVIII:C, von Willebrand Factor (vWF) and Fibrinogen Are Independent of Regional Myocardial Blood Flow (RMBF) |
| |
- |
Modulation of Platelet Adhesion by Antithrombin |
| |
- |
The 807C/T Polymorphism in the a-Subunit of Integrin a2b1 Modulates Platelet Adhesion onto Immobilized Collagen Under Arterial Flow Conditions |
| London FS |
- |
Development of Platelet Binding Sites for Factor Xa in A Platelet Subpopulation Responding to Synergistic Stimulation Requires Transglutaminase-catalyzed Serotonin Derivatization of Molecules Binding Through Serotonin and Integrin Receptors |
| |
- |
Sustained Calcium Influx in a Subpopulation of Platelets, Stimulated by PAR-1 Agonist Platelet Activation, Is Required for and Precedes the Exposure of Factor IXa Binding Sites and Factor X-Activation Complex Assembly |
| Londy F |
- |
Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis |
| Long GL |
- |
Homozygous Protein C Deficiency: Identification of a Mutation with Clinical and Laboratory Heterogeneity |
| Long GL |
- |
Evidence for Loci Pleotropically Influencing Inter-Related Clotting Factors |
| |
- |
Linkage Analysis Reveals No Evidence for Loci Other than the Factor VII Gene Influencing Factor VII Levels |
| Long A |
- |
Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes |
| Longo C |
- |
Prophylaxis using a Novel Oral Small Molecule Inhibitor to the P-selectin Receptor Promotes Thrombus Resolution in a Baboon Model of Venous Thrombosis |
| Longstaff C |
- |
Is the Conversion of Single-chain to Two-chain Tissue Plasminogen Activator Part of a Deactivation Pathway Rather than Enzyme Activation |
| |
- |
Use Of Fluorescent Protein Fusions of Tissue Plasminogen Activator as a Tool for Investigating Fibrinolysis In Vitro |
| Loof A |
- |
The Nijmegen Haemostasis Assay to Study the Interplay between Coagulation and Fibrinolysis |
| Loof AH |
- |
Low Amounts Of rVIIa Are Sufficient to Trigger Initiation of Thrombin Generation in Factor VII Deficient Patients |
| |
- |
Discrepancy between FVIII Activity Peak Levels and Thrombin and Plasmin Generation in Severe Hemophilia A Patients Treated with FVIII |
| Loof A |
- |
Determination of Platelet Activation Biomarkers Using the Surface Enhanced Laser Desorption/Ionisation Time of Flight (SELDI-TOF) Proteomic Approach |
| |
- |
Screening Fibrinolytic Disorders with the Nijmegen Haemostasis Assay |
| |
- |
The Effect of Statin Therapy on Coagulation and Fibrinolysis in Patients with Heterozygous Familial Hypercholesterolemia |
| Loogna K |
- |
Experience of Surgery with Continuous Infusion at Karolinska University Hospital in Patients With Hemophilia A and B, von Willebrand'S Disease and FVII-Deficiency |
| Lopaciuk S |
- |
Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke |
| |
- |
Severe Hemophilia in Poland Focus on Hemophilic Arthropathy |
| |
- |
Factor X Deficiency: Clinical Manifestation of 102 Subjects with Mutations in Factor 10 Gene |
| Lopatina EG |
- |
Home Treatment of Patients with Hemophilia Using Clotting Factor Concentrates VIII and IX Ahemphil A and Ahemphil B |
| Lopes NH |
- |
Evaluation of Hemostasis Changes Between Patients Underwent Coronary Artery Bypass Graft (CABG) with and without Cardiopulmonary Bypass. Partial Results of MASS-III Study |
| Lopéz JA |
- |
Relationship of Lipid Rafts and the Platelet Cytoskeleton |
| López F |
- |
Factor XIII Val34Leu Polymorphism Showed an Adverse Pharmacogenetic Effect on the Thrombolytic Therapy for Acute Myocardial Infarction |
| Lopez LR |
- |
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease |
| López JA |
- |
aIIbb3 Binds a Site within the von Willebrand Factor (VWF) A1 domain: A Critical Role in Thrombus Formation |
| Lopez LR |
- |
Circulating oxLDL/b2GPI Complexes, Autoantibodies and Intima-media Thickness in Patients with Systemic Lupus Erythematosus: Possible Role in Autoimmune-mediated Atherosclerosis |
| Lopez de Sa E |
- |
Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| López-Sánchez ML |
- |
Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic? |
| Lopez-Sendon J |
- |
Bleeding Events with Lytics and Thienopyridines in Patients with ST-Segment Elevation Myocardial Infarction. The Global Registry of Acute Coronary Events |
| Lopp A |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Loraine F |
- |
Independent Regulation of Platelet p38 MAP Kinase by the Collagen Receptor a2b1 |
| Lord ST |
- |
Insights from Structure/Function Analysis of Recombinant Fibrinogens |
| Lord ST |
- |
Functional Characterization of the FXIII Cross Linking Sites in the Fibrinogen g-Chain |
| Lorent N |
- |
New Mutation Inducing a von Willebrand 2A Disease |
| Lorenz M |
- |
Otamixaban, a Direct Factor Xa Inhibitor, More Potently Inhibits Experimental Coronary Thrombosis than Bivalirudin, a Direct Thrombin Inhibitor |
| |
- |
The New Anticoagulant Octaparin Displays High Antithrombotic Action in Venous Thrombosis in Rabbits and Rats without Impairment of Hemostasis |
| Lorenz M |
- |
Inhibition of thrombin generation by Otamixaban (XRP0673), a direct and selective factor Xa inhibitor |
| Lorenz M |
- |
Fractalkine Mediates Leukocyte Recruitment to Inflammatory Endothelial Cells in Flowing Whole Blood |
| Lorenzet R |
- |
Effect of Paclitaxel on the Coagulation/Fibrinolytic System Pattern in Cancer and Host's Tumor-Associated Cells |
| |
- |
Inhibition of the Renin-Angiotensin System Modulates the Procoagulant/Fibrinolytic Potential of Human Breast Carcinoma Cells |
| Lorenzini JL |
- |
Influence of 10 Polymorphisms Located in Genes Coding for Factors Involved in Coagulation and Fibrinolysis on the Risk of Venous Thrombosis in Factor V Leiden Homozygotes: Study of 233 Subjects |
| |
- |
Management of Glanzmann's Thrombasthenia Surgery: Contribution of Thrombelastogram (ROTEM®) |
| Lorenzoni R |
- |
Aspirin-Clopidogrel Combination and Trans-Esophageal Echo Parameters Predictive of Thromboembolism in Atrial Fibrillation: The CLAAF-Pilot Study |
| Loreth RM |
- |
High Inter-Device Variation of the PFA-100 Platelet Function Analyzer |
| Loreth R |
- |
Self-assessment of Bleeding in Young Women Results from a Multicenter Questionnaire |
| Loreth RM |
- |
Acquired Glanzmann's Thrombasthenia Associated with Trastuzumab (Herceptin®) Therapy: A Case Report |
| Lorie L |
- |
Role of FcRg and FXIII in Coated Platelet Formation and Platelet Procoagulant Activity in Mice |
| Loriot MA |
- |
A Mutation in Vitamin K Epoxide Reductase Complex Subunit-1 (VKORC1) in a Patient with Vitamin K Antagonist Resistance |
| Losert U |
- |
Inhibition of the Transcription Factor EGR-1 Significantly Reduces Neointima Formation in a Rabbit Iliac Artery Angioplasty Model |
| Loskutoff DJ |
- |
A Role for Adipocyte-enriched Transcription Factor, PPAR-g, in Up-regulation of PAI-1 Gene Expression during Adipogenesis |
| Loskutoff DL |
- |
Auto-Amplification of TNF-Alpha: A Potential Mechanism for the Maintenance of Elevated TNF-Alpha in Male But Not Female Obese Mice |
| |
- |
Expression, Regulation and Functional Significance of KC Chemokine During Adipose Development and Obesity |
| Losonczy G |
- |
A Novel Homozygous Mutation (1619delC) in GPIIb Gene Associated with Glanzmann Thrombasthenia, the Decay of GPIIb-mRNA and the Synthesis of a Truncated GPIIb Unable to Form Complex with GPIIIa |
| |
- |
Three Novel Heterozygous Mutations in a Patient with Type II Glanzmann Thrombasthenia |
| Lotan H |
- |
Dynamic Responsiveness to Aspirin in Patients Undergoing PCI |
| Lotti LV |
- |
Collagen-Induced Platelet Shape Change Does Not Require Positive Feedback Activators and Is Insensitive to cAMP Elevating Agents |
| Lotto V |
- |
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism |
| |
- |
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project |
| Loubele S |
- |
ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice |
| |
- |
Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice |
| Loubele S |
- |
A Hypercoagulable State in Myeloperoxidase Deficient Mice |
| |
- |
Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice |
| Loughman A |
- |
Fibronectin-Binding Protein (FnBP) Mediates Staphylococcus Aureus-Induced Platelet Aggregation |
| Lourenço DM |
- |
The Behavior of Anticardiolipin Antibodies Levels in Patients with Venous Thromboembolism |
| |
- |
Anticardiolipin Antibodies (ACL), Factor V Leiden (FVL) and G20210A Prothrombin Mutation (G20210AII) Do Not Predispose Renal Transplant Recipients to Thrombotic Complications or Graft Loss |
| |
- |
Hemostatic Changes in Patients with Malaria |
| Lourenssen GJACM |
- |
Relevance of Very Low Titres of Factor VIII Inhibitors in Nijmegen-Bethesda Assay-Negative Patients |
| Louvain-Quintard VB |
- |
Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas |
| Love B |
- |
Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin |
| Lovey PY |
- |
A Second Swiss Family with Upshaw-Schulman Syndrome (Hereditary Thrombotic Thrombocytopenic Purpura, TTP): Clinical Course and Molecular Findings |
| Low J |
- |
A Minor Variation of the APTT Mixing Test Can Be Used to Identify Defects in the Contact Mechanism |
| |
- |
Combining Pretest Probability Score and Antigenic Assays in the Diagnosis of HIT A Viable Alternative to Functional Assays |
| |
- |
How Useful is the Monitoring of (Low Molecular Weight) Heparin Therapy by Anti-Xa assay? The Laboratory Perspective |
| |
- |
A Mechanism of Impaired Platelet Response to ADP Stimulation in the CLIC1 Knockout Mice |
| |
- |
Towards Harmonisation of D-dimer Assays |
| Low J |
- |
Diagnostic Dilemma of a Patient with Strong Lupus Anticoagulant and Intramuscular Haemorrhage, Requiring Treatment with Recombinant FVIIa |
| |
- |
Comparison of Four D-Dimer Tests Combined with Clinical Probability Assessment to Exclude Deep Venous Thrombosis in Symptomatic Outpatients |
| Lowe G |
- |
Associations of Inflammatory and Haemostatic Variables with the Risk of Recurrent Stroke |
| Lowe GDO |
- |
Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis |
| |
- |
Circulating Inflammatory Markers and Risks of Cardiovascular and Noncardiovascular Disease |
| |
- |
Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study |
| |
- |
Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation |
| |
- |
Plasma Fibrinogen and Viscosity and Risk of Cognitive Decline in Elderly Patients with Vascular Risk Factors or Disease |
| Lowe G |
- |
Which Haemostatic Variables Add to the Prediction of Cardiovascular Events by Conventional Risk Factors? The Caerphilly Study |
| Lowe GDO |
- |
Risk of Deep Vein Thrombosis in Carriers of Factor V Leiden: Case-Controls vs Cohort Studies |
| Lowe GD4 |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Lowenhoff T |
- |
Drug Induced Changes in Fibrin Clot Permeability in Patients with Coronary Artery Disease |
| Löwenhoff T |
- |
Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia |
| Lown J |
- |
Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates |
| Lozano ML |
- |
Ciclooxygenase-1 C50T Polymorphism Modulates the Thromboxane A2 Level and might Affect the Efficacy of Aspirin |
| |
- |
Antagonism of TxA2 Receptor Plays a Major Role in the Inhibitory Effect of Flavonoids in Platelet Function |
| |
- |
Platelet Dysfunction Associated with Reduced Gai Expression in a family with Inherited Bleeding Disorder |
| |
- |
Clearance of Latent and Polymeric Antithrombin. Are These Conformational Variants Prothrombotic? |
| LPA De Piano |
- |
Evaluation of Hemostasis Changes in Patients Underwent Coronary Artery Bypass Graft (CABG). The Partial Results in a Brazilian Hospital |
| López JA |
- |
Receptors, Rafts, and Microvesicles in Thrombosis and Inflammation |
| López-Fernández MF |
- |
Oral Anticoagulant Treatment (OAT) with Portable PT Monitor in Primary Health Care Centres with Immediate Dose Adjustment by the Hospital OAT Unit |
| Lépine-Martin M |
- |
The Whole Blood Platelets Aggregation Test for HIT Diagnosis |
| Lu D |
- |
Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins |
| Lu X |
- |
Determination of the Integrin Binding Properties of the Disintegrin-Like Loops of ADAM Proteins |
| Lu Y |
- |
Prevalence of Deep Vein Thrombosis in Trauma: A Prospective Study of Orthopaedic Trauma Patients in Tianjin Hospital, China |
| Lu H |
- |
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication |
| Lu Q |
- |
Snake Venoms and Haemostasis |
| Lu D |
- |
A Sequence Derived from Loop I of PDGF Inserted into Neurotoxin Dendroaspin Scaffold Has an Ability to Inhibit Cell Proliferation and Migration |
| Lu X |
- |
A Sequence Derived from Loop I of PDGF Inserted into Neurotoxin Dendroaspin Scaffold Has an Ability to Inhibit Cell Proliferation and Migration |
| Lu D |
- |
Dendroaspin, a Disintegrin-Like Venom Protein, Inhibits the Protective Effect of Fibrinogen on the Apoptosis of A375 Cells |
| Lu X |
- |
Dendroaspin, a Disintegrin-Like Venom Protein, Inhibits the Protective Effect of Fibrinogen on the Apoptosis of A375 Cells |
| |
- |
Development of a Bifunctional Inhibitor with Anticoagulant and Anti-Platelet Activity |
| Lu D |
- |
Development of a Bifunctional Inhibitor with Anticoagulant and Anti-Platelet Activity |
| Lu X |
- |
Heterogeneity of Integrin Expression on Platelet Microparticles. Use of A Snake Venom Disintegrin as a Functional Probe |
| Lu S |
- |
Development of ADP-coated Bead Columns for Ticlopidine Monitoring |
| Lu A |
- |
Cofactor Binding Dependent Hydrogen Bond Formation between Antithrombin III Strand 3A Tyrosine-220 and Strand 5A Glutamic Acid 374 Is Necessary for Backwards Conformational Adjustments Leading to Fully Developed Ionic Interactions between the Pentasaccharide and ATIII, and for Stabilization of High Affinity Heparin Binding |
| Lu G |
- |
The Affinity of Protein C for the Thrombin-Thrombomodulin Complex Is Determined in a Primary Way by Active Site-Dependent Interactions |
| Lu X |
- |
Generation of Kininogen Deficient Mice |
| Lu D |
- |
Acquired Risk Factors Play a Major Role in Venous Thrombosis in Chinese Population |
| Lubbers D |
- |
Platelet Function Analyser Is a Good Alternative for Classical Bleeding Time to Detect von Willebrand Disease and Thrombocytopathy |
| Lubenow N |
- |
A Historical Comparison of Danaparoid (with or without Coumarin) Versus Ancrod (with or without Coumarin), or Coumarin Alone, for the Treatment of Heparin-Induced Thrombocytopenia (HIT): Evidence That Treatment Experience Can Influence Choice of Anticoagulant Rather Than Approval Status |
| Lubetsky A |
- |
Statins Confer a Direct Anti-Platelet Effect in Patients with Acute Myocardial Infarction Treated with Aspirin and Clopidrogel: Ex-vivo and in-vitro Study Results |
| |
- |
Platelet Function of Preterm and Full Term Newborns Tested by The Cone and Plate(let) Analyzer Correlates with Gestational Age |
| |
- |
Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice |
| |
- |
High Rate of Unresponsiveness to Clopidogrel in Patients with Acute Coronary Syndrome (ACS) As Determined by the Impact-R [Cone And Plate(let) Analyzer] |
| |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| Luboshitz J |
- |
Concomitant Infusion of Low Doses of rFVIIa and FEIBA in Severe Hemophilia A Patients with an Inhibitor to Factor VIII Who Are Refractory to rFVIIa or FEIBA Has an Excellent Hemostatic Effect and Synergistically Enhances Thrombin Generation |
| Luboshitz J |
- |
Autologous Bone and Marrow Grafted within a Clot of Platelet Rich Plasma Construct Normal Viable Bone |
| Lubusky M |
- |
Prevalence of Inherited Thrombophilia in Severe OHSS |
| Lucarini L |
- |
Asymmetric Dimethyl Arginine (ADMA), Homocysteine and Semicarbazide-Sensitive Amine Oxidase Activity (SSAO): New Markers of Oxidative Stress in Acute Coronary Syndromes |
| |
- |
Thrombophilia Is Frequent in Superficial Vein Thrombosis and Is Associated with Recurrence: A Retrospective Study |
| Luchinkina E |
- |
The Occasions of Factor XII Deficiency in Children |
| Luciani J |
- |
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets |
| Luciani M |
- |
Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development |
| Luckner D |
- |
No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children |
| Ludlam CA |
- |
Endothelial Progenitor Cells Are Mobilized Following Coronary Angiography |
| Ludlam C |
- |
Blood Leukocyte mRNA Expression of CD34 and VEGFR-2 Is Reduced, But Ve-cadherin and CD14 mRNA Expression Is Increased Following Elective Abdominal Aortic Aneurysm Repair |
| Ludlam CA |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Ludwig RJ |
- |
Carbohydrate-Based P-Selectin Antagonists: In vitro- and In Vivo Investigations of Structure-Activity Relationships |
| |
- |
Chemically Distinct Anticoagulants Exert Differential Effects on Experimental Melanoma Metastasis |
| Luettgen J |
- |
Evaluation of a Novel Direct Factor VIIa Inhibitor in Rabbit Models of Arterial Thrombosis and Hemostasis |
| |
- |
Antithrombotic Effects of the Direct Factor Xa Inhibitor Razaxaban in Canine Models of Thrombosis |
| Lugos MD |
- |
The Use of Cow-Brain Tissue as an Alternative Source of Tissue Thromboplastin for Prothrombin Time Tests |
| Lugovskaya NE |
- |
Molecular Composition of Soluble Fibrin at Various Diseases and Fibrinolysis Products Reacting with D-dimer-Specific Monoclonal Antibody III-3b |
| Lugovskij E |
- |
D-dimer-Induced Derangement of Endothelial Extracellular Matrix Partially Is Mediated by TSP-1-Dependent Activation of TGFbeta1 |
| Lugovskoy EV |
- |
Molecular Composition of Soluble Fibrin at Various Diseases and Fibrinolysis Products Reacting with D-dimer-Specific Monoclonal Antibody III-3b |
| Lugovskoy EV |
- |
New Polymerization Sites in the Bb1553 Fragment of Fibrin Molecule |
| Lukas JC |
- |
Population Pharmacokinetics of the ReFacto® Factor VIII for Prophylactic Treatment of HIV- and HIV+ Individuals with Haemophilia A |
| Lukasik M |
- |
Effect of the 807C/T Polymorphism in Platelet Glycoprotein Ia on the Relationship between Carotid Artery Intima-Media Thickness and Platelet Activation |
| Lukes A |
- |
Quality of Life (QoL) Evaluation in Women with Menorrhagia and Inherited Bleeding Disorders |
| |
- |
Multi-Site Comparison of Platelet Function Testing |
| |
- |
Treatment and Management of Women with Bleeding Disorders and Menorrhagia (WBDM) Study: Laboratory Diagnosis |
| Lukinius A |
- |
Tissue Factor Is Associated with a Negative Outcome of Clinical Islet Transplantation |
| Lund T |
- |
Interleukin-8 (IL-8) Generation in Whole Blood Is Related to Markers of Atherosclerosis |
| |
- |
The Eskimo Diet: More Than Omega-3 Fatty Acids |
| Lundström NM |
- |
Acetaminophen Inhibits Platelet Function Dose-dependently in Volunteers |
| Lundström T |
- |
Prothrombotic Risk Assessment of Patients Receiving Ximelagatran for Secondary Prevention of Venous Thromboembolism |
| Lunghi B |
- |
Intragenic and Extragenic Components Modulating Coagulation Factor VIII Levels and the Risk of Venous Thrombosis |
| |
- |
CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction |
| |
- |
Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients |
| |
- |
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism |
| Luo G |
- |
Generation of Kininogen Deficient Mice |
| Lupattelli L |
- |
Postoperative Pulmonary Embolism Detected by Multi-slice Computerized Tomography (MSCT) after Lung Surgery FcOR Cancer |
| Lupescu O |
- |
Arterial Thrombosis Complicating Limb Trauma |
| |
- |
Muscular Crushing-Thrombotic Disorder of the Injured Limb |
| Lupo E |
- |
Thrombophilia in Young Adults with Ischemic Stroke Not Related to Cardiovascular Risk Factors |
| Lupu C |
- |
Tissue Factor Pathway Inhibitor-2 Inhibits in vitro Endothelial Cell Migration and Angiogenesis |
| Lupu F |
- |
Tissue Factor Pathway Inhibitor-2 Inhibits in vitro Endothelial Cell Migration and Angiogenesis |
| Lupu C |
- |
Caveolin-1 Expression Regulates Cell Surface Exposure and Anticoagulant Function of Tissue Factor Pathway Inhibitor |
| Lupu F |
- |
Caveolin-1 Expression Regulates Cell Surface Exposure and Anticoagulant Function of Tissue Factor Pathway Inhibitor |
| Lussana F |
- |
Platelet Aggregation Studies: Autologous Platelet-Poor Plasma Inhibits Platelet Aggregation When Added to Platelet-Rich Plasma to Normalize Platelet Count |
| Lutty G |
- |
Nanoparticle Tethered Biosensors for Autoregulated Gene Therapy in Hyperoxic Endothelium |
| Lutze G |
- |
Comparative Investigation of Prothrombin Complex Concentrates: Differences in Levels of Markers Indicating Activation of Coagulation |
| Luu H |
- |
Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures |
| Lux PAG |
- |
Annexin A5 Regulates the Engulfment Protein Repertoire on the Membrane of PS Expressing Apoptotic Cells |
| Luxembourg B |
- |
Thrombophilia in Inherited Antithrombin Deficiency |
| Luxembourg B |
- |
Development and Clinical Evaluation of Two Chromogenic Substrate Methods For Monitoring Fondaparinux Sodium |
| |
- |
Prevalence of Acquired and Hereditary Thrombophilic Disorders in Women with Pregnancy Loss |
| Luxembourg B |
- |
Monitoring of Aspirin and Clopidogrel Response in Patients with Arterial Occlusive Disease with Different Platelet Function Methods |
| Luxembourg B |
- |
Prevalence and Clinical Significance of Anti-b2-Glycoprotein-I-Antibodies in Patients with Venous Thrombosis |
| |
- |
Use of Native or Platelet Count Adjusted Platelet-Rich Plasma for Platelet Aggregation Measurements |
| |
- |
Elevated Factor IX, XI and XII-Activities Are Associated with an Increased Risk for Venous Thrombosis |
| Luzak B |
- |
Effect of the 807C/T Polymorphism in Platelet Glycoprotein Ia on the Relationship between Carotid Artery Intima-Media Thickness and Platelet Activation |
| |
- |
Does Pycnogenol Intensify Efficacy of Acetylsalicylic Acid in the Inhibition of Platelet Function? |
| |
- |
Polymorphisms C807T, G873A and G1648A of Platelet Glycoprotein Ia in Young Adults with Ischemic Stroke |
| Luzzatto G |
- |
Prevalence of Helicobater Pylori Infection and Clinical Response to Eradication Therapy in Patients Wwith Immune Thrombocytopenic Purpura (ITP) |
| Lwaleed B |
- |
Tissue Factor Synthesis and Expression by Human Proximal Tubular Cells: the Source of Increased Urinary Tissue Factor Secretion in Disease? |
| |
- |
Quantitation of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Human Semen |
| |
- |
Does Human Semen Contain a Functional Haemostatic System? A Possible Role for Tissue Factor Pathway Inhibitor in Fertility through Semen Liquefaction |
| |
- |
Seminal Factor VIII and von Willebrand Factor: A Possible Role of the Conventional Clotting System in Human Semen? |
| Lwaleed BA |
- |
Monocytes and Plasma Tissue Factor Levels in Normal Individuals and Patients with Lower-Limbs Deep Venous Thrombosis: Potential Diagnostic Tools? |
| Lyman GH |
- |
Elevated Platelet Count Increases the Risk of Thromboembolism during Outpatient Chemotherapy |
| |
- |
Risk Factors for Chemotherapy-Associated Venous Thromboembolism in a Prospective Observational Study: A Proposed Predictive Model |
| Lyons R |
- |
An Open-Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of AMG 531 in Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura |
| Lyutova L |
- |
Hemorheology, Hemostasis in Patients with Arterial Hypertension |
| |
- |
Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts |
| |
- |
Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases |